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Abstract
The effect of monovalent salt on the activity and stability of citrate 
synthase from the moderately halophilic Archaeon Haloferax volcaniiwas 
investigated by assay of enzyme activity over a range of Na+ and K+ 
concentrations and by thermal inactivation experiments over a range of 
K+ concentrations.
Based on a 38 residue N-terminal amino acid sequence obtained, 
from Hf. volcanii citrate synthase, oligonucleotides were designed and 
used to probe restriction digests of Hf. volcanii genomic DNA. A 2.9 kb 
genomic fragment was identified by hybridisation to one of these probes. 
This fragment did not contain the citrate synthase gene; however, a 939 
bp open reading frame within this fragment showed significant (33-47%) 
identity with several bacterial genes involved in the metabolism of sugar- 
nucleotides. The structural features of this open reading frame are 
discussed and possible functions in glycolipid and glycoprotein 
biosynthesis suggested.
To aid the cloning of the citrate synthase, further amino acid 
sequence data was obtained from the protein. Citrate synthase was 
purified by an improved affinity chromatography method, using biospecific 
elution. Cyanogen bromide cleavage of the purified enzyme yielded a 6 
kD fragment. Amino acid sequence internal to the enzyme was obtained 
from this fragment.
PCR primers were designed to the N-terminal and internal amino 
acid sequences and used to amplify a 960 bp product from genomic DNA. 
This product is of the size predicted from the relative positions of the 
amino acid sequences used to design the PCR primers. Due to time 
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1.1 The diversity of Archaeal phenotypes
A striking feature of the group of organisms that we know as the 
archaebacteria, or Archaea, is their range of extreme requirements and 
tolerances for growth. Although in general their phenotypes can be thought of 
as either methanogenic, thermophilic or halophilic, within these broad 
categories are found autotrophic, heterotrophic, anaerobic, aerobic, 
acidophilic and alkaliphilic representatives.
The methanogens are obligate anaerobes, some of which are 
thermophilic or halophilic, that metabolise carbon dioxide to methane. 
Thermophiles may have growth optima anywhere between 55 and 110°C, 
some also requiring highly acidic conditions. A large proportion of them 
reduce sulphate or elemental sulphur to hydrogen sulphide to obtain energy. 
The halophilic Archaea require salt concentrations of greater than 1 M NaCI 
for growth and include representatives that also require highly alkaline 
conditions; their internal salt environments are isotonic with the exterior, but 
KCI replaces NaCI.
In terms of cellular and sub-cellular morphology there is little to 
distinguish the Archaea from the eubacteria, a fact which originally led to 
their taxonomic grouping with the latter as prokaryotes. Their physiological 
peculiarities, such as ether-linked lipids and unusual cell wall structure were
ascribed to convergent evolution and their extremophilic natures to 
adaptations to their environments. Molecular analysis has since revealed that 
the Archaea must be considered as phylogenetically distinct from both the 
eubacteria and the eukaryotes.
1.2 Archaeal Phylogeny
The way in which we view the evolutionary history of life was 
revolutionised by the first thorough analyses of 16s rRNA sequence data and 
subsequent inference of previously unknown phylogenetic relationships 
(Woese & Fox, 1977, Woese et al., 1978). The prokaryote/eukaryote 
dichotomy was replaced, after some controversy, by the division of life into 
eukaryotes, eubacteria and archaebacteria that is now generally accepted. It 
has recently been proposed that these groups be given the status of 
"domains" (Eukarya, Bacteria and Archaea respectively), the archaebacteria 
being renamed the Archaea to emphasise their distinction from the 
eubacteria (Woese ef a/., 1990).
The Archaea are sub-divided into two main branches: the 
Crenarchaeota, comprising mainly acidophilic and sulphur-dependent 
thermophiles and the Euryarchaeota, which include the extreme halophiles, 
the methanogens, sulphate-reducers and some thermophiles (Figure 1.1).
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1.2.1 The root of the universal tree
The position of the root shown on the 16S rRNA tree (Woese et a/., 1990) 
has been determined from the data of Gogarten et al. (1989) and Iwabe et al. 
(1989) who used pairs of paralogous genes (that were assumed to have 
arisen by duplication events in the last common ancestor of all life) to locate 
the root between the Bacteria and Archaea. The root has simply been drawn 
on the rRNA tree at the equivalent position.
Studies on glutamate dehydrogenase genes (Benachenhou et al.,
1993, Forterre et al., 1993) have revealed that they are also suitable for 
rooting the universal tree by a similar method to that used by Iwabe et al., 
where one of a pair of ancestrally duplicated genes is used as an outgroup to 
root the tree of the other. Using several different phylogenetic inference 
methods these workers did not find it possible to root the tree 
unambiguously. Forterre et al. (1993) have also suggested that the way in 
which Iwabe et al. performed their calculations was not statistically sound. 
Regardless of the method of analysis, the currently accepted rooting is 
based on only two gene pairs and therefore needs further testing before it 
can be regarded as certain.
1.2.2 How valid is the Archaeal tree ?
Since the original proposal for the existence of three branches of life, 
which was based on partial rRNA sequences, the data have been augmented 
by complete sequencing of many 16S rRNAs, increasing the resolution of the 
tree. Phylogenetic trees deduced from 23S rRNA (Leffers etal., 1987), 
ribosomal proteins (Auer et al., 1990), DNA dependent RNA polymerases
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(Zillig et al., 1989a,b), protein elongation factors and ATPases (Iwabe et al., 
1989) support the three domain scenario. Acceptance of this relationship has 
by no means been unanimous; a number of objections have been raised, 
either to the topology of the 16S rRNA tree (specifically to the monophyletic 
nature of the Archaea) or to the validity of any tree based on a single 
molecular feature such as 16S rRNA sequence.
1.2.3 Objections to the Archaeal tree
In the past Lake has argued that the algorithms which support the 
archaeal tree are subject to errors caused by unequal rate effects, where 
rapidly changing sequences are artefactually grouped together (Lake, 1988, 
1989). He put forward the evolutionary parsimony algorithm as a more 
suitable alternative on the basis that it is insensitive to unequal rate effects. 
The branching pattern obtained is different from the archaeal tree: the 
sulphur-dependent thermoacidophiles group with the eukaryotes while the 
halophiles and methanogens group with the eubacteria, thus the Archaea 
appear polyphyletic (Figure 1.2). Although this view has had some support, it 
has been refuted by the proponents of the archaeal topology (Olsen & 
Woese, 1989,1993) on the basis of the regions of sequence chosen for the 
analysis and the way in which they were aligned.
Zillig et a/.(1989a,b) do not contest the existence of the Archaea, but 
have interpreted sequence data from DNA-dependent RNA
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Figure 1.2 Universal phylogenetic tree according to Lake
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polymerases as showing that the eukaryotes have arisen from a fusion of an 
ancestral eubacterium and Archaeon.
More fundamental objections are raised by Margulis and Guerrero (1991) 
and by Mayr (1990), who dispute the importance of the molecular data and 
who see the structural and genetic differences between "prokaryotes" and 
eukaryotes as paramount. For these reasons Margulis and Guerrero would 
prefer a five kingdom system to be adopted and Mayr a system based on two 
domains. Their proposals are discussed more fully in Mayr (1991), Woese et 
al. (1991) and Wheelis etal. (1992).
1.2.4 A conflict of assumptions, not of data
The arguments surrounding the validity of the various trees stem 
mainly from differences of opinion on the aims of classification (to show 
evolutionary relationships, or to act as an information retrieval system) and 
on the mathematical treatment of the available data. There are several 
stages at which critical choices must be made: truly homologous sequences 
must be chosen and aligned with minimal gaps, regions of the alignment 
suitable for analysis must be identified and finally the phylogenetic inference 
method(s) selected. There may be a number of equally valid options at each 
stage. (For a review see Beanland & Howe, 1992.) From the available data 
the division of life into three domains appears safe, although the current 
rooting of the tree must be taken with some caution.
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1.3 Haloferax volcanii
Haloferax volcanii is a moderately halophilic Archaeon originally 
isolated from the Dead Sea (Mullakhanbhai & Larsen, 1975). At 30°C it 
requires a minimum of 1 M NaCI for growth, the optimum being 1.7 M NaCI. 
Hf.volcanii has a high tolerance for magnesium, as would be expected for an 
organism isolated from the Dead Sea, which contains 1.1 -1.5 M Mg2+. It is 
capable of growing on a simple, defined minimal medium, allowing the 
isolation of auxotrophic strains (Mevarech & Werczberger, 1985).
The Hf.volcanii genome consists of a circular 2.9 Mbp chromosome 
and four plasmids of 690, 442, 89 and 6.4 kbp. Detailed physical mapping of 
the Hf.volcanii genome has yielded a set of overlapping cosmid clones that 
cover 96% of the total sequence (Charlebois ef al., 1990,1991). The 
Hf.volcanii genome contains fewer mobile insertion sequences than those of 
other halophilic Archaea, (Halobacterium halobium, for example) making it 
relatively stable.
The development of transformation techniques (Charlebois etal., 
1987) and E.coli I Hf.volcanii plasmid shuttle vectors (Lam & Doolittle, 1989, 
Holmes et al., 1991) has established Hf.volcanii in the field of halophile 
molecular biology.
1.4 The citric acid cycle
The citric acid cycle is the site of the terminal reactions of aerobic 
catabolism in eukaryotes and eubacteria, acting as a source of reducing 
equivalents for ATP synthesis (Figure 1.3). The cycle also provides a pool of 
biosynthetic precursors for anabolic processes.



























Figure 1.3 The citric acid cycle
The position of citrate synthase is indicated (CS).
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There has been no thorough study on the presence of the oxidative 
cycle in Archaea. All of the cycle's enzymes have been reported in 
Halobacterium halobium (Aitken & Brown, 1969) and some in aerobically 
grown Thermoplasma acidophilum (Danson, 1988). Key enzymes (citrate 
synthase and succinate thiokinase) have been reported in a number of 
halophiles (Danson et al., 1985). It is likely that a complete cycle is operative 
in these organisms.
An oxidative cycle may operate in sulphur-dependent Archaea growing 
heterotrophically and aerobically (Sulfolubus species, for example) as some 
of the required enzymes activities have been observed [see Danson, (1988) 
for review]. Those sulphur-dependent Archaea that grow autotrophically also 
possess the majority of the citric acid cycle enzymes, however they appear 
to be involved in CO2 fixation via a reductive pathway (SchSfer et al., 1986)
1.5 Citrate synthase
1.5.1 The available data
Citrate synthase (EC 4.1.3.7) acts as a major control point in the citric acid 
cycle, catalysing the condensation of oxaloacetate and acetyl coenzyme A to 
form citrate and coenzyme A. The enzymes of the Gram negative bacteria 
are hexameric and are allosterically inhibited by NADH, while those of Gram 
positive bacteria, eukaryotes and Archaea are dimeric and are insensitive to 
NADH, but are isosterically inhibited by ATP. In all cases the subunit relative 
molecular mass is 45-50 kD.
As a consequence of its metabolic importance, citrate synthase has 
been extensively studied. The gene sequences of number of citrate
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synthases have been determined from a wide variety of sources, shown in 
Table 1.1
pig kidney (Evans etal., 1988)
Saccharomyces cerevisiae mitochondria (Rosenkrantz et a i, 1986)
Saccharomyces cerevisiae glyoxysome (Rosenkrantz et a i, 1986)
Arabidopsis t ha liana (Unger et al., 1989)
Escherichia coli (Ner et a i, 1983)
Acinetobacter anitratum (Donald etal., 1987)
Acetobacter aceti (Fukaya etal., 1990)
Pseudomonas aeruginosa (Donald etal., 1989)
Bacillus coagulans (Schendel etal., 1992)
Rickettsia prowazekii (Wood etal., 1987)
Coxiella burnetii (Heinzen et a i, 1991)
Tetrahymena thermophila (Numata et a i, 1991)
Mycobacterium smegmatis (David etal., 1991)
Thermoplasma acidophilum (Sutherland etal., 1990)
Table 1.1 Citrate synthase gene sequences currently available
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Crystal structures are available for both the pig and chicken heart 
enzymes (Remington etal., 1982, Liao etal., 1991). Preliminary 
crystallographic data have recently been obtained for the citrate synthase of 
the Archaeon Tp.acidophilum (Russell etal., 1993).
The crystallographic data show that the enzyme is composed almost 
entirely of a-helices. Each subunit consists of a large and small domain, with 
the active site located in a cleft between them. Each subunit contributes 
residues to the active site of the other. Multiple sequence alignments 
(Henneke et a!., 1990) have shown that the majority of the twelve active site 
residues are conserved between all eubacterial and eukaryotic citrate 
synthases.
Two forms of the enzyme have been observed: the "open" form in 
which the active site is accessible to the solvent and the "closed" form where 
the solvent has no access to the active site, providing acetyl coenzyme A is 
bound. The open form has a binding site for oxaloacetate in the active site, 
but none for acetyl coenzyme A. When oxaloacetate binds, the large and 
small domains rotate relative to each other and the enzyme assumes the 
closed form, which can then bind acetyl coenzyme A. The open form 
mediates substrate entry and product release, while the closed form carries 
out catalysis (Remington, 1992). Figure 1.4 shows a diagram the secondary 
structure of a pig heart citrate synthase monomer and space-filled 
representations of its dimer in both open and closed forms.
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Figure 1.4 Structural diagrams of pig heart citrate synthase
"Open" (a) and "closed" (b) forms of the pig heart citrate synthase 
dimer, from Remington (1992). The two obvious clefts in the open form 
indicate the position of the active sites.
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1.5.2 The citrate synthase mechanism
In order to bring about the condensation of acetyl coenzyme A and 
oxaloacetate, citrate synthase must first deprotonate the methyl carbon of the 
acetate moiety, using only the weak acids and bases of its amino acid side 
chains. Simultaneously, oxaloacetate must be activated, making it a suitable 
target for nucleophilic attack.
The catalytic mechanism has been extensively studied in pig heart 
citrate synthase (Karpusas et a/., 1990, Alter etal., 1990). From studies of 
the binding of acetyl coenzyme A and the proposed transition state analogue 
carboxymethyl coenzyme A, residues His274 and Asp375 have been 
identified as acting in concert on acetyl coenzyme A (Karpusas et a i, 1990, 
Karpusas et ai, 1991). These residues are thought to promote formation of a 
neutral enol by general acid-base catalysis. Almost any mutation of the 
catalytic residues results in a substantial increase of the enzyme's stability to 
thermal inactivation (Wang et a i , 1991). This was taken to indicate that in 
the native enzyme these residues are held in unfavourable positions such 
that their pKa values are radically changed from their solution values, 
enabling them to deprotonate the methyl carbon.
Bound oxaloacetate is surrounded by three arginines and two 
histidines, polarizing the carbonyl bond and making it prone to nucleophilic 
attack (Karpusas etal., 1990). The stereospecificity of the reaction is 
explained by the binding of oxaloacetate, as only one side of the molecule is 
open to attack, the other being obscured by the enzyme.
The subsequent condensation step is proposed to occur as the planar
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enol attacks the C3 of oxaloacetate and the proton originally donated by 
His274 is recycled by passing back to that residue. Figure 1.5a summarises 
these steps.
The resulting citryl coenzyme A intermediate is then hydrolysed by a 
mechanism that has not been fully characterised. Remington (1992) has 
suggested that hydrolysis by an activated water molecule may occur (Figure 
1.5b), while Alter et al. (1990) suggest that an anhydride is formed with 
Asp375 prior to a similar hydrolysis by an activated water molecule. After the 
condensation step Asp375 is protonated, enabling it to donate the proton to 
the thioester sulphur atom and thereby activate it, since sulphonium ions are 
good leaving groups (Figure 1.5c).
Mutation of the active site aspartate of the Escherichia coli citrate 
synthase (Man etal., 1991) has shown that this residue is involved in the 
hydrolysis step. When changed to glutamate the forward reaction rate is 
greatly reduced, although the hydrolysis of citryl-coenzyme A is unaffected. 
This has led them to propose a reaction scheme which does not involve the 
aspartate residue until the hydrolysis step, assuming that a carbanion is 
formed, instead of a neutral enol (Figure 1.5d). They propose that the 
developing carbanion is stabilised by the partial positive charge on the 
carbonyl of oxaloacetate. The E.coli enzyme may therefore operate by a 
slightly different mechanism to the eukaryotic enzyme.
1.5.3 Citrate synthase as a model enzyme
The extensive database of structural and mechanistic information 
available for citrate synthase make it an ideal candidate for comparative
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molecular enzymology. It is a widely occurring enzyme which has a 
conserved function in all organisms where it occurs and as such is suitable 
for phylogenetic analysis.
Citrate synthase has been reported in the three major groups of 
Archaea (Danson et a i , 1985), presenting an opportunity to compare the 
structures of thermophilic and halophilic enzymes with those already 
determined for a variety of mesophiles.
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Figure 1.5a Enolisation and condensation steps
This proposed mechanism is based on data from the pig heart 
enzyme.
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Figure 1.5b Hydrolysis step mechanism
H SCoA
This proposed mechanism is based on data from the pig heart 
enzyme. B- represents an unknown base on the enzyme surface.
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Figure 1.5c Hydrolysis via anhydride formation
This proposed mechanism is based on data from the pig heart 
enzyme.
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Figure 1.5d Carbanion formation and condensation steps
This proposed mechanism is based on data from the E.coli enzyme.
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1.6 The structure of halophilic enzymes
The structural features of halophilic enzymes that are responsible for 
their extreme salt requirements are not well defined. In the absence of any 
X-ray crystallographic data, techniques such as light, X-ray and neutron 
scattering and analytical centrifugation have been used to probe enzyme 
structures in solution.
It is evident from the primary amino acid compostions of halophilic 
enzymes that they are generally acidic compared to their mesophilic 
counterparts and contain a higher proportion of borderline hydrophobic 
residues (Lanyi, 1974). Current data suggest that the acidic residues are 
clustered in surface loops surrounding a core similar to a mesophilic protein. 
Lanyi concluded that at low salt concentrations (< 0.5 M) the predominant 
reason for salt dependence is the shielding of the many negative charges on 
the protein, while at higher concentrations hydrophobic interactions become 
more important.
Studies on the malate dehydrogenase (hMDH) of Haloarcula 
marismortui led to the proposal of a model for the stabilization of halophilic 
proteins under high salt conditions (Zaccai & Cendrin, 1989, Zaccai & 
Eisenberg, 1990, Eisenberg et al., 1992). It is argued that the acidic groups 
on the surface of the protein form a quaternary structure that coordinates 
hydrated salt ions at a higher concentration than in the bulk solvent. The 
surface carboxyl groups are assumed to act cooperatively as there are 
otherwise too few to account for the amount of hydrated salt ions bound 
(approximately 500 Na+ ions, 500 Cl" ions and 4000 water molecules per 
hMDH dimer). This salt binding corresponds to 0.35 g NaCI and 0.85 g water
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per gram of protein, an exceptionally high value when one considers that 
non-halophilic proteins bind 0.2-0.4 g of water and negligible amounts of salt. 
When dissociated into monomers by lowering the salt concentration, hMDH 
lost its unusual salt and water binding capacity, behaving more like a non- 
halophilic protein. This was taken as evidence to support the involvement of 
quaternary structure in salt binding.
The stabilization model has since been revised following the cloning, 
sequencing and expression in E.coli of the hMDH gene (Cendrin et ai, 1993). 
The original model assumed the enzyme to be dimeric and of subunit relative 
molecular mass 87 kD, as determined by light and neutron scattering and 
analytical centrifugation (Zaccai & Cendrin, 1989). The relative molecular 
mass deduced from the sequence data is however 32.6 kD. The accuracy of 
data obtained from analytical centrifugation and light scattering has been 
improved and the neutron and X-ray data re-analysed, leading to the 
conclusion that hMDH is in fact a tetramer of about 140 kD relative molecular 
mass (Bonnete etal., 1993).
The calculations of the amounts of salt and water bound are 
significantly affected by these new data; the tetramer appears to bind 
approximately 0.4 g water and 0.1 g NaCI or KCI per gram of protein. This is 
about the same amount of water and about ten-fold the amount of salt as a 
non-halophilic protein. The water binding ability of hMDH does not change 
significantly upon dissociation of the tetramer in low salt conditions (1 M 
NaCI); the monomers appear to remain partially folded with the same solvent 
binding characteristics as the tetramer.
Studies on the elongation factor Tu of H.marismortui (hEF-Tu) provide 
evidence to support this stabilization model (Baldacci etal., 1990). The
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translated gene sequence of hEF-Tu was compared with those of E.coli and 
Methanococcus vanielii (a methanogenic Archaeon), revealing the expected 
excess of acidic residues in the hEF-Tu sequence. The predicted antigenicity 
of hEF-Tu was determined by the method of Parker et al. (1986) and 
compared with the predictions for E.coli and M.vanielii. The data suggest that 
nearly all the acidic residues in hEF-Tu are located on the protein surface. By 
locating the equivalent residues on the X-ray structure of the E.coli EF-Tu it 
appears that the acidic residues in hEF-Tu occur in patches on the exterior of 
the protein.
Further evidence for the presence of surface charge clusters as a 
common feature of halophilic proteins has been presented by Bohm and 
Jaenicke (1994), who constructed a homology model of the Hf.volcanii 
dihydrofolate reductase (hDHFR) based on the crystal structure of the E.coli 
enzyme. These workers considered halophilicity in terms of the enzyme's 
instability at low salt concentrations, rather than it's ability to function at high 
salt concentrations.
They observed that hDHFR retained activity under acid conditions, in 
the absence of monovalent salt. This was explained by suggesting that the 
driving force behind the inactivation in low salt was the charge repulsion 
between the negative surface residues no longer shielded from each other by 
salt ions. Under acid conditions these residues are protonated and 
electrostatically neutral, preventing disruption of the protein structure.
The hDHFR model identified five surface clusters of 2-3 amino acids 
each (aspartate and glutamate) that may be relevant to the protein's 
halophilic properties. One of these clusters occurs at the C-terminal end of 
an a-helix, an unusual feature as this is the negative end of the helix dipole
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(the dipole moment of an a-helix is approximately 0.5 - 0.75 of a negative 
charge at the C-terminal end, and a similar positive charge at the N-terminal 
end). Bohm and Jaenicke termed this a "halophilic helix motif'as in general 
positive charges are preferred at the C-termini of helices (Richardson & 
Richardson, 1988).
1.7 Biotechnology of halophilic systems
The characteristics of the halophilic Archaea have not yet been widely 
exploited in biotechnological processes. Present areas of interest include 
applications of isolated halobacterial purple membrane and the production of 
biopolymers by Haloferax mediterranei.
The photosensitive, proton-pumping membranes of some halobacteria 
have been isolated in a highly stable and active form which has potential 
uses in photoelectric cells and photosensitive films (Rodriguez-Valera,
1991).
Under certain growth conditions Hf.mediterranei can be made to 
accumulate the high molecular weight polymer, poly-p-hydroxybutyrate in 
intracellular granules. This material is used in the manufacture of 
biodegradable plastics (Rodriguez-Valera etal., 1989).
The unusual water-retaining properties of halophilic enzymes have yet 
to be applied in any industrial fermentations. These enzymes may find future 
applications as biocatalysts in non-aqueous media, particularly hydrophilic 
solvents which are thought to denature enzymes by stripping essential water 
molecules from them (Klibanov, 1989). Under these very low water 
conditions enzymes become rigid and as a consequence exhibit novel 
substrate specificities and increased thermostability (Klibanov, 1989, Gupta,
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1992). An extracellular protease from Halobacterium halobium has been 
shown to be stable and active in the polar organic solvents DMSO and 
ethyleneglycol; furthermore, its activity changes from amide hydrolysis to an 
esterase activity, enabling it to catalyse peptide syntheses (Ryu & Dordick,
1993).
Halophilic enzymes may also find applications in aqueous 
environments maintained at high solute concentrations, such as in industrial 
processes where operation at a high substrate or product concentration 
would be advantageous.
In the long term it may be possible to engineer features that confer 
halophilicity into enzymes with useful catalytic activities, if such general 
features can be identified.
1.8 Aims of this project
Using citrate synthase as a model, our group hopes to identify features 
that confer on archaeal enzymes their stability to extremes of temperature 
and salinity. This is to be achieved by comparison of high resolution three 
dimensional structures, coupled with mutational studies to test the 
deductions.
We aim to clone, sequence and express at high level citrate synthase 
from a variety of Archaea whose growth optima span the temperature range 
of 30 to 110°C and salinity range up to saturation. Once sufficient pure 
protein is available, crystallisation and rational mutagenesis studies will 
follow.
The protein sequence data inferred from the citrate synthase gene 
sequences will be used to construct phylogenetic trees, with the aim of
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further clarifying the phylogeny of the Archaea and their evolutionary 
relationship to other organisms.
The halophilic Archaeal citrate synthases we intend to study are those 
from the moderate halophile, Haloferax volcanii and the extreme halophile, 
Halobacterium halobium. As part of our overall scheme, this project aims to 
clone, sequence and express at high level the gene for citrate synthase of 
Hf. volcanii, either in a mesophilic host, or in a Hf. volcanii citrate synthase- 
deficient mutant. Sequence data obtained will be subject to phylogenetic 
analysis, while expressed protein will be used to begin crystallisation studies.




Chromatography: DEAE-Sepharose CL-6B was supplied by 
Pharmacia Biotech Ltd., Milton Keynes, UK, Hydroxylapatite Bio Gel HT by 
Bio-Rad Laboratories Ltd. Herts., UK and Matrex gel Red A by Amicon 
Corporation, MA, USA.
Citrate synthase assays: Coenzyme A (CoA) was supplied by 
Calbiochem-Novobiochem, Nottingham, UK, 5,5'-dithiobis-(2-nitrobenzoic 
acid) (DTNB) and oxaloacetic acid by Sigma Chemical Co. Ltd., Poole, UK.
Electrophoresis: Acrylamide Sequagel and Protogel were supplied by 
National Diagnostics Ltd., NJ, USA, and N.N.N'N-tetramethylethylene 
diamine (TEMED) by Sigma. Protein molecular weight standards were 
supplied by Bio-Rad Laboratories Ltd. Agarose (standard and low melting 
point (LMP)) and ethidium bromide solution were supplied by Sigma.
Blotting: Genescreen transfer membrane was supplied by DuPont 
NEN Research Products, Stevenage, UK, Hybond N membrane by 
Amersham International, Aylesbury, UK and Immobilon P transfer membrane 
by Millipore Ltd., Watford, UK. Whatman 3MM chromatography paper was 
supplied by Whatman Scientific Ltd., Maidstone, UK.
Bacterial culture: Yeast extract, tryptone, casamino acids and Bacto- 
agar were supplied by Difco Laboratories, Ml, USA. Ampicillin (sodium salt) 
was supplied by Sigma.
Molecular biology: Restriction enzymes were supplied by Pharmacia 
and by Gibco BRL Life Technologies Ltd., Uxbridge, UK. Alkaline 
phosphatase was supplied by Pharmacia, Klenow DNA polymerase and Taq 
DNA polymerase by Gibco BRL or by Northumbria Biologicals Ltd (NBL), 
Cramlington, UK. Lambda DNA, Lambda DNA Hind\\\ and Pst\ digests, 5- 
bromo-4-chloro-3-indolyl-p-D-galactoside (X-Gal) and isopropyl-p-D- 
thiogalactoside (IPTG) were supplied by NBL. NENsorb 20 columns were 
supplied by DuPont NEN and Geneclean II kits by Bio 101, La Jolla, CA, 
USA. Magic Miniprep kits were obtained from Promega Corporation, Wl, 
USA. Low molecular DNA markers were supplied by Bio-Rad Laboratories 
Ltd. Sequenase kits were supplied by United States Biochemical Corp., 
Ohio, USA. Dithiothreitol was supplied by ICN Biomedicals Ltd., High 
Wycombe, UK. Redistilled phenol was supplied by Rathbum Chemicals Ltd., 
Walkerbum, UK.
Radiochemicals: Adenosine-5'-triphosphate, tetra 
(trimethylammonium) salt, [y 32p] 3000Ci/mmol was supplied by DuPont 
NEN and deoxyadenosine-5'-(a-thio)-triphosphate, [a35S] 1000Ci/mmol by 
ICN Biomedicals Ltd.
Oligonucleotides were synthesised on an Applied Biosystems 381A 
DNA synthesiser or were ordered through Pharmacia's custom 
oligonucleotide synthesis service.
Polyallomer Quick-seal ultracentrifuge tubes were supplied by 
Beckman Instruments Inc., USA and X-ray film by Fuji Photo Film Co., 
Japan.
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All other reagents (SLR, AnalaR and Aristar grades) were supplied by 
BDH Ltd., Poole, UK and Fisons, Loughborough, UK.
DNA and amino acid sequence analysis was carried out using the 
GCG Sequence Analysis Software Package Version 6.0 (Devereux et ai., 
1984).
2.0.1 Bacterial strains, culture conditions and plasmids
Haloferax volcanii (DSM 3757"*") was obtained as a freeze-dried culture 
from Deutsche Sammlung von Mikrooganismen und Zellkulturen, Germany. 
Hf.volcanii was grown in liquid batch culture in DSM medium 372 (200 g 
NaCI, 20 g MgS04.7 H2O, 2g KCI, 36 mg FeCl2-4 H2 0 , 0.36 mg 
MnCl2.4H2 0 , 3 g trisodium citrate, 1 g sodium glutamate, 5 g yeast extract 
and 5 g casamino acids per litre, pH 7.2.) at 37°C, shaken at 180 rpm.
Frozen stocks were maintained at -70°C in the same medium containing 15% 
glycerol.
Escherichia coli K12 HB101 F" pro" leu~ thi" Smr endol” recA" r\<c nriK“ 
and E.coli K12 JM105 thi rpsL endA sbcB15 hspR4 A(lac-proAB)(F' traD36 
proAB lacN Z M15) was grown in 2xYT medium (16 g tryptone, 10 g yeast 
extract and 5 g NaCI per litre) at 37°C, shaken at 200 rpm. When required 
the medium was solidified by addition of 1.5% agar. Frozen stocks were 
maintained at -20°C and -70°C in the same medium containing 30% glycerol.
Ampicillin resistance plasmids were maintained or selected for in solid 
and liquid media by addition of ampicillin to a concentration of 100 pg ml-1.
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2.1 General methods
2.1.1 Manipulation of Hf.volcanii
2.1.1.1 Culture of Hf.volcanii
A freeze-dried culture was used to inoculate 50 ml of DSM medium 
372 (Section 2.0.1) and grown for 5 days. Subsequent 1 litre cultures were 
inoculated with 5 ml of growing cells. After inoculation, 1 litre cultures were 
grown for 5-7 days. Cells were harvested by centrifugation at 8000g for 10 
minutes in a Sorvall GSA rotor. Typical yield was 7-8 g litre-1 (cell pellet wet 
weight). The cell pellets were stored in sterile tubes at -20°C until required.
Plates were prepared by addition of 1.5% (w/v) agar to DSM medium 
372. Colonies generally appeared 5 - 1 0  days after plating out cells. Plates 
were stored at 4°C for up to 4 weeks, or until the medium started to become 
dry and crystalline. When growing liquid cultures from plates a single colony 
was used to inoculate 20 ml of DSM medium 372.
2.1.1.2 Preparation of cell extract from Hf.volcanii
Cell pellets were resuspended (approximately 0.2 g ml-1) in 20 mM 
Tris-(hydroxymethyl)-methylamine (Tris) -HCI (pH 8.0), 2 mM (disodium) 
ethylenediaminetetraacetate (EDTA) containing the required concentration of 
KCI or glycerol. The suspension was sonicated on ice in an MSE 150 Watt 
Ultrasonic Disintegrator Mk2 using a 9.5 mm probe. Four to six 20-second 
bursts were used, with 30 seconds cooling time between each. Cell debris
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2.2.1.1 FPLC Superdex 200 gel filtration
The column was run in 20 mM Tris-HCI (pH 8.0), 2 mM EDTA, 2 M KCI 
at 1 ml min-1. The enzyme was loaded using a 2 ml loop and 1 ml fractions 
were collected after the void volume (30 ml).
2.2.1.2 Matrex Gel Red A column
Columns of 10 ml bed volume were prepared in 10 ml disposable 
syringes plugged with siliconised glass wool. These columns were found to 
run freely under gravity at 1-2 ml min“1. A column was first equilibrated with 
20 mM Tris-HCI (pH 8.0), 2 mM EDTA, 0.1 M KCI. Cell extract (10 ml) in the 
same buffer was passed through a 0.45 pm filter and loaded onto the 
column. The column was washed with 150 ml equilibration buffer to remove 
unbound proteins. Citrate synthase was eluted with 20 ml of 0.2 mM 
coenzyme A, 1 mM oxaloacetate in the same buffer, collecting in 2 ml 
fractions.
After each use the column was cleaned with 30 ml of 5 M urea, 0.5 M 
NaOH and washed with 200 ml Milli Q water before re-equilibrating.
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2.2.5 SDS polyacrylamide gel electrophoresis
Pre-mixed Protogel 30% acrylamide, 0.8% N N' -methylene 
bisacrylamide was used. Acrylamide solution, gel buffer concentrate and 
water were mixed according to the table below and polymerised by the 
addition of ammonium persulphate and TEMED to a final concentration of 
0.07% (w/v) and 0.075% (v/v) respectively.
Stacking gel buffer concentrate was 0.49 M Tris-HCI (pH 6.8), 0.4% 
(w/v) SDS. Resolving gel buffer concetrate was 1.50 M Tris-HCI (pH 8.9), 







13 16 2 1.8
Gel buffer 
concentrate/ml
12 12 12 4.8
distilled
water/ml
23 20 16 7.2
Samples were diluted two-fold in 0.125 M Tris-HCI (pH 6.8), 0.04% 
(w/v) SDS, 20% (w/v) sucrose, 10% (v/v) p-mercaptoethanol, 0.04% (w/v) 
bromophenol blue and boiled for 2 minutes prior to loading on the gel.
Gels were run in 0.052 M Tris, 0.001% (w/v) SDS, 0.4% (w/v) glycine. 
Small (60 x 100 x 1 mm) gels were run on an Atto Corp. Mini-Atto system at 
10 mA (stacking gel) and 20 mA (resolving gel). Large (160 x 160 x 2 mm)
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gels were run on a Bio-Rad Protean II xi system at 20 mA (stacking gel) and 
30 mA (resolving gel). All were run at constant current.
The protein standards used were from Biorad (low molecular weight 
range): Phosphorylase b (Mr 97,400), Bovine serum albumin (Mr 66,200), 
Ovalbumin (Mr 45,000), Carbonic anhydrase (Mr 31,000), Soybean trypsin 
inhibitor (Mr 21,500) and Lysozyme (Mr 14,400).
Gels were stained in 45% (v/v) methanol, 10% (v/v) acetic acid, 0.25% 
(w/v) Coomassie Blue R for 30-60 minutes and destained in 5% (v/v) 
methanol, 7.5% (v/v) acetic acid.
2.2.6 Western blotting
A large polyacrylamide gel was run as described above, although the 
gel was not stained. A 100 x 100 mm region containing the protein bands 
was cut from the gel and a blotting sandwich prepared with this region alone. 
The blotting sandwich was set up in the following order:
Five 100 x 100 mm sheets of Whatman 3MM paper soaked in blotting 
buffer (50 mM Tris, 50 mM glycine, 20% (v/v) methanol), the gel section, two 
100 x 100 mm sheets of Immobilon P (Polyvinylidene difluoride) membrane 
(pre-wetted in 100% methanol and then soaked in blotting buffer for 10 
minutes) and a further five 100 x 100 mm sheets of Whatman 3MM paper 
also soaked in blotting buffer.
The sandwich was placed in a blotting tank containing 3.5 litres of 
blotting buffer pre-cooled to 4°C and electrophoretically blotted at 4°C for 15 
hours at 200 mA constant current.
The gel was then removed and stained with Coomassie Blue R as 
described above. The membranes were stained for 15 minutes in 50%
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methanol, 10% (v/v) acetic acid, 0.025% (w/v) Coomassie Blue R and 
destained for 20-30 minutes in several changes of 50% (v/v) methanol, 10% 
(v/v) acetic acid. The membranes were then washed 3 times in Milli Q water 
for 20 minutes, sealed in bags while still wet and stored at -20°C.
2.2.7 Citrate synthase assays
Citrate synthase activity was measured spectrophotomerically by the 
method of Srere et al. (1963). Free coenzyme A reacts with 5,5-dithio bis-2- 
nitrobenzoate (DTNB), releasing thionitrobenzoate which has an absorbtion 
maximum at 412 nm and a molar extinction coefficient of 13,6001 m oM crrH .
Assays were carried out at 30°C in a Perkin Elmer Lambda 3B 
spectrophotometer. Initial rates were calculated using the PECSS software 
supplied with the instrument. 1 unit of enzyme activity is defined as the 
amount which produces 1 pmol of product min“1.
Unless otherwise specified, assays were carried out in 1 ml of 20 mM 
Tris-HCI (pH 8.0), 2 mM EDTA, 2 M KCI containing 0.2 mM oxaloacetate, 0.4 
mM acetyl coenzyme A and 0.1 mM DTNB.
2.2.8 Acetylation of coenzyme A
Coenzyme A was acetylated by dissolving 10 mg CoA in 1 ml of Milli 
Q water, cooling on ice and adding 0.2 ml of 1 M KHCO3, followed by 0.1 ml 
of 1 M acetic anhydride freshly diluted with Milli Q water. This gives a seven­
fold molar excess of acetic anhydride over CoA. After incubation on ice for 
10 minutes, acetylation was checked by addition of a 20 pi sample to assay 
buffer containing DTNB.
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2.3 DNA methods
2.3.1 Quantitation of DNA
DNA concentrations were determined spectrophotometrically by 
measurement of absorbance at 260 and 280 nm. An absorbance of 1 at 260 
nm corresponds to approximately 37 pg (single-stranded) or 50 pg (double­
stranded) DNA. An A260^a 280 ratio of greater than 1.8 was taken to indicate 
purity (Maniatis etal., 1982).
2.3.2 DNA preparation methods
2.3.2.1 Preparation of genomic DNA from Hf.volcanii
Genomic DNA was prepared by a modification of the method of 
Holmes & Dyall-Smith (1991).
15 ml of culture was transferred to a sterile 50 ml tube and spun at
3,000 rpm for 10 minutes in a benchtop centrifuge to pellet the cells.
The pellet was resuspended in 6 ml of TE pH 8.0 containing 0.5% 
SDS, 100 pg ml"1 proteinase K and incubated at 37°C for 1 hour.
1 ml of 5.0 M NaCI was added and mixed thoroughly, followed by 0.8 
ml of 8% (w/v) hexadecyltrimethyl ammonium bromide (CTAB), 0.6 M NaCI. 
The mixture was incubated at 65°C for 10 minutes.
The supernatant was removed to a clean, sterile tube and extracted 
with an equal volume of chloroform/isoamyl alcohol for 10 minutes.
The phases were separated by spinning at 2000 rpm for 5 minutes and 
the supernatant transferred to a clean, sterile tube. 0.6 Volumes of
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isopropanol were added to the supernatant. The precipitated DNA was 
transferred to 70% (v/v) ethanol by spooling onto a sterile glass rod.
The DNA was washed with 70% (v/v) ethanol, allowed to air-dry and 
dissolved in 2 ml of TE pH 8.0.
2.3.2.2 Plasmid DNA 'Maxiprep' method I
Log phase E.coli culture (1 ml) was used to inoculate 500 ml 2xYT, 
containing ampicillin (100 pg ml-1) which was then grown overnight. The 
cells were spun down for 10 minutes at 8,000g in a Sorvall GSA rotor. The 
pellet was resuspended in 2 ml of 25 mM Tris-HCI (pH 8.0), 50 mM glucose, 
10 mM EDTA and transferred to a 30 ml Corex tube.
NaOH (4 ml of 0.2 M) containing 1% (w/v) SDS was added, mixed by 
inversion and incubated on ice for 5 minutes. Ice-cold potassium acetate (3 
ml of 3 M, pH 4.8) was added, mixed by inversion and incubated on ice for 
10 minutes.
Cell debris was removed by spinning in a Sorvall SS-34 rotor at 
8,000g for 20 minutes at 4°C. The supernatant was made up to 10 ml with 
distilled water and the DNA purified by caesium chloride density gradient 
cetrifugation.
2.3.2.3 Caesium chloride equilibrium density gradient
centrifugation
To the 10 ml of DNA solution prepared by the 'Maxiprep' method I, 
10.17 g caesium chloride was added. This was sealed in a 13 x 51 mm 
Beckman Quick-Seal ultracentrifuge tube and spun at 55,000 rpm for 24 
hours at 4°C in a Beckman Ti70 rotor.
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The plasmid DNA was recovered under UV illumination using a 
syringe and 19G needle and extracted three times with an equal volume of 
water-saturated butanol to remove the ethidium bromide. The DNA was then 
precipitated with ethanol, washed in 70% (v/v) ethanol, dried and dissolved 
in 0.5 ml of TE (pH 8.0).
2.3.2.4 Plasmid DNA 'Maxiprep1 method il
Cells were grown overnight in 100 ml 2xYT, containing ampicillin (100 
pg ml-1) after inoculation with 1 ml of log phase E.coli culture.
The cells were spun in a benchtop centrifuge at 3,000 rpm for 10 
minutes and the pellet resuspended in 4 ml of 25 mM Tris-HCI (pH 8.0), 50 
mM glucose, 10 mM EDTA. NaOH (8 ml of 0.2 M) containing 1% (w/v) SDS 
was added, mixed by inversion and incubated on ice for 10 minutes. Ice-cold 
potassium acetate (6 ml of 3 M, pH 4.8) was added, mixed by inversion and 
incubated on ice for 15-30 minutes. Cell debris was removed by spinning at
3,000 rpm for 15 minutes in a benchtop cetrifuge.
The supernatant was added to 18 ml of propan-2-ol and incubated on 
ice for 30 minutes. The precipitated nucleic acid was pelleted in a benchtop 
centrifuge at 3,000 rpm for 20 minutes. The pellet was dissolved in 1 ml of 
TE (pH 8.0), 1 ml of 6 M LiCI was added and incubated on ice for 15 
minutes. The precipitate was removed by spinning in a microcentrifuge for 10 
minutes. The supernatant was added to 4 ml of absolute ethanol and the 
nucleic acids precipitated at -20°C for 30 minutes.
The precipitate was pelleted in a microcentrifuge for 10 minutes, 
washed with 70% (v/v) ethanol, dried and dissolved in 0.4 ml of TE (pH 8.0). 
To the solution, 4 pi of 10 mg ml"1 RNAse A was added and the mixture
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incubated at 37°C for 30 minutes. To inactivate the RNAse 20 |j| of 10%
(w/v) SDS was added, the solution was heated to 75°C for 10 minutes, 0.42 
ml of 6 M LiCI was added and mixture incubated at room temperature for 15 
minutes. The precipitate was pelleted in a microcentrifuge for 10 minutes and 
the supernatant added to 2 ml ethanol containing 40 pi of 3M sodium 
acetate (pH 5.2); DNA was precipitated at -20°C for 30 minutes.
The DNA was pelleted in a microcentrifuge for 10 minutes, washed 
with 70% (v/v) ethanol, dried and dissolved in 0.4 ml of distilled water. The 
DNA solution was extracted once with phenol / chloroform and twice with 
chloroform and ethanol precipitated. The precipitate was pelleted in a 
microcentrifuge for 10 minutes, washed with 70% (v/v) ethanol, dried and 
dissolved in 0.1 ml of distilled water.
This procedure yields 400-800 pg plasmid DNA suitable for restriction 
digests or sequencing, without CsCI density gradient centrifugation.
2.3.2.5 Plasmid DNA 'Minipreps'
Small-scale isolation of plasmid DNA was carried out by the alkaline 
lysis method of Maniatis et a/.(1982).
2.3.2.6 Plasmid DNA 'Magic Minipreps1
Plasmid DNA was isolated using the Magic Minipreps kit, following the 
manufacturer's instructions.
2.3.3 Restriction digests of DNA
DNA was digested with the appropriate enzyme under the buffer 
conditions specified by the manufacturer. When the DNA was digested with
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two enzymes requiring different buffer concentrations, the first enzyme was 
heat inactivated under the conditions recommended by the supplier and 
further 10x buffer was added to the reaction mixture prior to addition of the 
second enzyme.
2.3.4 Agarose gel electrophoresis of DNA
Agarose gels containing 0.6-1.0% (w/v) agarose were made with 1x 
Tris-acetate-EDTA (TAE) buffer containing 0.5 pg mM ethidium bromide. 
Loading buffer (6x concentration) was 40% (w/v) sucrose, 0.25% (w/v) 
bromophenol blue, 0.25% (w/v) xylene cyanol. Gels were run at 6 VcrrM 
(Plasmid DNA and plasmid digests) or 2 VcrrM (genomic DNA digests) in 1x 
TAE buffer. When the DNA bands were to be cut from the gel and purified, 
ultra-pure low-melting point agarose was used.
2.3.5 Recovery of DNA from agarose gels
DNA was recovered from low-melting point agarose gels by a 
modification of the freeze-sqeeze method of Tautz & Renz (1983). The gel 
slice was placed in a 0.5 ml Eppendorf tube which had been pierced at the 
base and the hole stopped with siliconised glass wool. The tube was frozen 
in liquid nitrogen for 30 seconds, placed into a 1.5 ml Eppendorf tube and 
spun in an micro centrifuge for 5 minutes. The eluent containing the DNA 
was collected.
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2.3.6 Purification of DNA fragments
Phenol was equilibrated with Tris-HCI (pH 8.0), phenol /  chloroform / 
isoamyl alcohol and chloroform / isoamyl alcohol extractions were performed 
as described by Maniatis et a/.(1989).
DNA was purified using NENsorb cartridges according to the 
manufacturer's instructions, eluting with 30% (v/v) ethanol. Aristar grade 
methanol was used to wet the columns. Alternatively, the Geneclean II kit 
was used to purify DNA fragments, according to the manufacturer's 
instructions.
Spun columns of Sepharose CL-6B, Sephadex G-25 and Sephadex G- 
50 were prepared in 0.5 ml Eppendorf tubes which had been pierced at the 
base and the hole stopped with siliconised glass wool. 400 pi of 50% slurry 
was packed by spinning inside a 1.5 ml Eppendorf tube. Four column 
volumes of TE (pH 8.0) were passed through by spinning under the same 
conditions and the DNA sample was loaded onto the dry column and re-spun 
into a fresh tube.
2.3.7 Precipitation of DNA
DNA precipitations were carried out using ethanol and sodium acetate 
as described by Maniatis et a/.(1982).
2.3.8 Ligation procedures
Ligation of cohesive ends was carried out using 0.1 Units of Gibco 
BRL T4 DNA ligase in the buffer supplied by the manufacturer. The ratio of 
insert to vector was approximately 5 to 1, estimated by ethidium bromide
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staining on agarose gel. Ligation was carried out overnight at 15°C in a total 
volume of 20 |jl.
The Gibco T4 ligase buffer is suitable for blunt-end ligations, which 
were therefore carried out under the same conditions except that the ratio of 
insert to vector was increased to approximately 10 or 20 :1.
2.3.9 DNA blotting techniques
2.3.9.1 Southern blotting
Restriction digests of plasmid DNA were carried out as described. 
Digests were run on 1 % (w/v) agarose gels in 1x TAE buffer at 2 - 6 Vcm-1, 
dependent upon the size of the DNA fragments. The size markers used were 
2 pg of X H/ndlll digested DNA.
Blotting onto Genescreen membrane was carried out by the capilliary 
method (Southern, 1975). The DNA was first denatured by incubation in 0.2 
M NaOH, 0.6 M NaCI for 30 minutes at room temperature. The gel was then 
washed three times in 10x SSC (1.5 M NaCI, 0.15 M sodium citrate) for 20 
minutes at room temperature. The Genescreen membrane was soaked in 
10x SSC for 10 minutes and the blotting stack was set up using a reservoir 
containing 10x SSC. Blotting was carried out for 18 hours. The membrane 
was removed and air dried. The DNA was baked onto the membrane at 80°C 
for 3 hours.
2.3.9.2 Dot blotting
The DNA sample was dissolved in water and spotted onto dry 
Genescreen membrane using a fine-tipped pipette. Generally 1 pg of DNA 
was applied in a single dot. The dot was allowed to dry and then the blot was
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treated with 1.5 M NaCI, 0.5 M NaOH and 1.5 M NaCI, 0.5 M Tris-HCI (pH 
7.2), 1 mM EDTA as described in 2.3.9.3 below. The blot was placed on a 
filter-paper pad soaked in 2x SSC for 2 minutes, air-dried and baked at 80°C 
for 2 hours.
2.3.9.3 Colony hybridisation
Gridded Hybond-N nylon membranes were placed on the surface of 
2xYT plates containing ampicillin (100 pg mM). Bacteria were streaked onto 
the membranes and grown overnight at 37°C. The membranes were placed 
on a pad of filter paper soaked in 1.5 M NaCI, 0.5 M NaOH for 7 minutes. 
They were then transferred to a fresh pad soaked in 1.5 M NaCI, 0.5 M Tris- 
HCI (pH 7.2), 1 mM EDTA for 3 minutes. This last step was repeated once 
and the membranes then washed in 2x SSC before being allowed to air-dry. 
The DNA was baked onto the membranes at 80°C for 2 hours.
2.3.10 Deprotection and purification of synthetic
oligonucleotides
Columns from the DNA synthesiser were opened and the resin 
removed to a 2 ml screw-cap tube containing 1ml concentrated ammonia. 
The resin was resupended and incubated at 55°C for 18 hours to cleave the 
DNA from the column and remove protecting groups.
The solution was cooled on ice, centrifuged to pellet the resin and the 
supernatant containing the DNA removed. The solution was dried under 
vacuum, dissolved in 0.5 ml distilled water, centrifuged to remove any 
remaining resin and precipitated with ethanol. The pellet was redissolved as
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before and precipitated a second time before finally dissolving in 0.5 ml of 
sterile Milli Q water.
2.3.11 End-labelling of oligonucleotides
Oligonucleotides were end-labelled with [y-32pj a t p  by incubating 20 
pmoles oligonucleotide with 100 pCi [y-32P] ATP (33 pmoles) and 10 units of 
T4 polynucleotide kinase in 1x kinase buffer (20 mM Tris-HCI (pH 7.6), 5 mM 
MgCl2, 5 mM dithiothreitol, 50 pg mM bovine serum albumin (BSA)) at 37°C 
for 30 minutes. Total reaction volume was 40 pi.
Incorporation of radiolabel was checked and unincoporated label 
removed by passing the solution through a Sephadex G-25 spun column (for 
17-20mers) or a G-50 spun column (for larger olignucleotides), as described 
under DNA purification methods.
2.3.12 Hybridisation of labelled oligonucleotide probes to DNA
blots
The dried membrane was sealed in a bag containing 50 ml pre­
hybridisation solution (5.2x SSC, 5x Denhardt's solution [0.1% (w/v) Ficoll, 
01% (w/v) polyvinylpyrrolidone, 0.1% (w/v) BSA], 0.1% (w /v), 0.6% (w/v) 
SDS, 20 pg ml"1 salmon sperm DNA). The salmon sperm DNA was boiled 
for 5 minutes and then cooled on ice for 5 minutes prior to addition. The 
membrane was incubated overnight at the desired temperature. To this, 20 
pmoles of labelled oligonucleotide probe were added and the membrane 
incubated for a further 12-18 hours.
The membrane was washed twice with 50 ml of 2x SSC, 0.1% (w/v) 
SDS at the same temperature, sealed in a plastic bag and autoradiographed
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using pre-flashed X-ray film and intensifying screens at -70°C. Two pieces of 
film were used, the first developed after 2 days, the second after 4-30 days 
depending on the intensity of the bands observed on the first.
2.3.13 Preparation of competent E.coli JM103 and HB101
Competent E.coli were prepared by the calcium chloride method. 
Growth medium (50 ml of 2xYT in a 250 ml flask) was inoculated with 1 ml of 
an overnight bacterial culture and grown at 37°C for 2 hours with vigorous 
shaking. The culture was chilled on ice for 10 minutes and spun at 2,500 rpm 
in a benchtop centrifuge for 5 minutes.
The supernatant was discarded and the cell pellet resuspended in 50 
ml of ice-cold, sterile 50 mM CaCl2- The cell suspension was kept on ice for 
30 minutes and the centrifugation repeated. The cells were resuspended in 5 
ml of ice-cold 50 mM CaCl2 and kept on ice for 60 minutes before use.
2.3.14 Transformation of competent E.co//JM103 and HB101 with
plasmid DNA
Competent cells (200 pi) were added to 5 pi of a ligation mixture and 
incubated on ice for 30 minutes in polypropylene tubes. The cells were heat- 
shocked at 42°C for 90 seconds and replaced on ice for 60 seconds. The 
culture was made up to 1 ml by addition of 800 pi of 2xYT and the cells 
incubated at 37°C for 1 hour without shaking. X-Gal (50 pi of 20 mg m M , in 
DMF) and IPTG (50 |jl of 24 mg-1 m M ) were added and 200-350 pi of the 
mixture plated on 2xYT agar containing ampicillin (100 pg mM). Plates were 
incubated at 37°C overnight.
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2.3.15 PCR techniques
2.3.15.1 PCR amplification of genomic DNA
Amplification was carried out using NBL and Gibco BRL Taq 
polymerases in 100 pi of 20mM Tris-HCI (pH 8.3), 25 mM KCI, 0.5-5 mM 
MgCl2, 0.1 mg mM BSA overlaid with 50 pi of mineral oil. Reactions were 
carried out in a Perkin Elmer Cetus DNA Thermal Cycler using Perkin Elmer 
GeneAmp reaction tubes.
Reaction mixtures contained 80 ng of target DNA, 50 pM dATP, 
deoxycytidine triphosphate (dCTP), deoxyguanosine triphosphate (dGTP) 
and deoxythymidine triphosphate (dTTP), primers at a concentration of 0.4 
pM each and 2.5 U of Taq polymerase. The mixture was heated to 94°C for 4 
minutes, maintained at 94°C while the polymerase was added and then 30 
reaction cycles were earned out using the following profile:
•  94°C for 1 minute
• 37°C-65°C for 1.5 minutes
• 72°C for 2 minutes.
A final 10 minute extension was run after the last cycle was complete. 
A 10 pi aliquot from each reaction was run on a 1% (w/v) agarose gel.
2.3.15.2 Asymmetric PCR
The technique of asymmetric PCR described by McCabe (1990) was 
used to generate single-stranded DNA by reamplification of a gel-purified 
PCR product.
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Reactions were carried out in 100 pi of 20 mM Tris-HCI (pH 8.3), 25 
mM KCI, 1.5 mM MgCl2, 0.1 mg mM BSA, overlaid with 50 pi of mineral oil. 
The ratio of primers was 50 pmoles to Ipmole. The primer to be extended 
into the single-stranded product was present in the greater amount.
The template was prepared by running 10 pi of a previous PCR 
reaction on a 1% (w/v) agarose gel, excising the band to be reamplified, 
recovering the DNA by freeze-squeeze followed by ethanol precipitation or 
using Geneclean and finally dissolving the dried pellet in 20 pi distilled water. 
Of this, 0.5 pi was used for each reamplification reaction.
The reactions were carried out as described above, the mineral oil was 
removed by extraction with chloroform and an equal volume of 4 M 
ammonium acetate was added to the aqueous phase. DNA was precipitated 
by adding isopropanol to a final concentration of 50% (v/v) and leaving the 
solution for 10 minutes at room temperature. The precipitate was pelleted by 
spinning for 10 minutes in a microcentrifuge, washed with ice cold 70% (v/v) 
ethanol and dried.
The pellet was dissolved in 7 pi of distilled water and sequenced using 
1 pmole of the PCR primer that was at the lower concentration in the 
amplification reaction. The sequencing procedure was identical to that for 
plasmid DNA, except that the denaturing step was omitted.
2.3.16 Sequencing plasmid DNA
Sequencing of double-stranded template DNA (pUC18) was carried 
out by the dideoxy chain termination method, using Sequenase kits and a- 
35S-dATP (1000Ci/mmol), according to the manufacturer’s instructions. For 
each set of 4 reactions 3-5 pg of template DNA were used. Between 1 and
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20 pmoles of primer were used per set of reactions. When sequencing close 
to the primer 1 pi of Sequenase Mn2+ buffer was added to the reaction 
mixture.
Sequencing reactions were run in Tris-borate-EDTA (TBE) buffer on 
0.4 mm thick 8% polyacrylamide gels made using Sequagel reagent kits. 
Gels were left 2-3 hours after pouring before use and were pre-run for 1 hour. 
Using a Bio-Rad Sequi-Gen II 50 x 21cm sequencing cell, gels were run at 
40-50 Watts constant power and at a constant temperature of 50°C. Gels 
were fixed in 10% (v/v) acetic acid, 10% (v/v) methanol for 15 minutes before 
drying under vacuum.
Dried gels were autoradiographed overnight, or longer if necessary.
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Chapter
Characterisation of activity and stability of Hf.volcanii 
citrate synthase
3.1 Introduction
The effect of monovalent salt concentration on the activity and 
stability of Hf.volcanii citrate synthase was studied under different 
conditions as a basis for the design of improved purification procedures. 
The effect of KCI concentration on stability was investigated by thermal 
inactivation experiments. These serve as the first steps in the thorough 
characterisation of the enzyme that will be necessary if it is to be used as a 
model for the study of halophilicity.
The studies described below were carried out on cell extracts 
prepared as described in Section 2.1.1.2. When citrate synthase assays 
were carried out on unfractionated extracts, background activities of 
coenzyme A hydrolysis were measured by assays omitting oxaloacetate. In 
cases where this rate was not zero, the background value was subtracted 
from the measured rate to give the citrate synthase activity.
The apparent Km values of the Hf.volcanii citrate synthase for 
oxaloacetate and coenzyme A have been determined as 38 pM and 75 pM 
respectively in 2M NaCI (Danson et al., 1985). This was taken as a guide to 
the enzyme's kinetic characteristics in 2M KCI: assays were therefore 
carried out in 200 pM oxaloacetate and 400 pM coenzyme A.
3.2 Salt dependence of citrate synthase activity
Cell extracts were prepared in 20 mM Tris-HCI (pH 8.0), 2 mM 
EDTA, containing either 0.5 M NaCI or KCI. Samples of 10 pi were assayed 
at increasing final concentrations of NaCI or KCI as shown in Figure 3.1. 
Each assay was carried out in triplicate.
3.3 Stability of citrate synthase
Cell extracts were prepared in 20 mM Tris-HCI (pH 8.0), 2 mM 
EDTA, containing either 0.5 M NaCI or KCI. Samples of 90 pi were diluted 
into 3 ml 20 mM Tris-HCI (pH 8.0), 2 mM EDTA, containing NaCI or KCI, to 
give final concentrations of 0, 0.05, 0.1, 0.5, 1, 2, 3 and 4 M salt. The 
enzyme solution was incubated at 25°C and 30 pi samples were assayed 
for citrate synthase activity in buffer containing 2 M NaCI or KCI after 0, 24, 
48 and 120 hours.
It was found that at NaCI or KCI concentrations below 0.1 M, total 
inactivation occurred within 24 hours. At higher concentrations of either salt 
no activity was lost during the 120 hour course of the incubation (data not 
shown).
3.4 Thermal inactivation of citrate synthase
Cell-free extracts were prepared in 20 mM Tris-HCI (pH 8.0), 2 mM 
EDTA containing 2 M KCI. A glass tube containing 2.85 ml of the same 
buffer was heated in a water bath and 150 pi of cell extract added. The 
solutions were mixed briefly with a 1 ml automatic pipette. Inactivations 
were carried out at 60, 62, 64, and 66°C. At higher temperatures the mixing










Figure 3.1 Dependence of citrate synthase activity on salt 
concentration
initial rates are plotted against the concentration of NaCI or KCI in 
the assay. Each point is the mean value of triplicate assays: the error bars 
indicate 1 standard deviation.
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process was found to produce transient cooling of the system, resulting in 
non-linear rates of inactivation. The effect became more marked with 
increasing inactivation temperatures.
Temperatures were measured using a thermocouple in a separate, 
identical tube and were maintained to within 0.2°C of the target temperature 
throughout the timecourse.
Aliquots of approximately 150 pi were removed at intervals, cooled 
rapidly by pipetting into ice-cold glass tubes and 50 pi of this sample were 
then assayed immediately. As it was not possible to measure hot liquids 
accurately with the air-displacement pipettes used, the rapid cooling of the 
aliquots by pipetting into an ice-cold glass tube was essential before 
removing the 50 pi for assay. A value for 100% activity was obtained by 
diluting 150 pi of cell-free extract into 2.85 ml of the same buffer at 4°C and 
assaying 50 pi aliquots. The rates of inactivation were determined by 
plotting the natural logarithm of the percentage initial activity as a function 
of time. The apparent first order rate constants are given by the slopes of 
these plots, which are shown in Figures 3.2-3.5.
According to transition-state theory, the relationship between the rate 
constant of a reaction and the absolute temperature can be expressed as:
k = kBTlh e‘AG°*/RT
Where k is the rate constant of the reaction, kB is Boltzmann's 
constant, h is Planck's constant, R is the gas constant, T is the absolute 
temperature in degrees Kelvin and AG°* is the free energy change in going 
from the ground state of the reactant(s) to the transition state (Creighton, 
1993).
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Figure 3.2 Thermal inactivation of citrate synthase at 60°C
The graph shows In (% initial activity) plotted against time in minutes. 
The rate constant of the inactivation k, equal to -(slope), is 8.3x10-4 min"1. 
Each point is the mean of triplicate independent inactivations; error bars 
indicate 1 standard deviation.
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Figure 3.3 Thermal inactivation of citrate synthase at 62°C
The graph shows In (% initial activity) plotted against time in minutes. 
The rate constant of the inactivation /c, equal to -(slope), is 1.7x10-3 min-1. 
Each point is the mean of triplicate independent inactivations; error bars 
indicate 1 standard deviation.
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Time (min)
Figure 3.4 Thermal inactivation of citrate synthase at 64°C
The graph shows In (% initial activity) plotted against time in minutes. 
The rate constant of the inactivation k, equal to -(slope), is 0.025 min-1. 
Each point is the mean of triplicate independent inactivations; error bars 
indicate 1 standard deviation.
















Figure 3.5 Thermal inactivation of citrate synthase at 66°C
The graph shows In (% initial activity) plotted against time in minutes. 
The rate constant of the inactivation k, equal to -(slope), is 0.233 min-1. 
Each point is the mean of triplicate independent inactivations; error bars 
indicate 1 standard deviation.
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Another form of this equation may be obtained by substituting:
AG°* = AH°* - TAS°*
Hence:
k = kBTlh ,e"AH°*/RT eAS°*/R 
Over small temperature ranges AS°*/R can be taken as a constant. 
Since, with any change in temperature, k varies proportionally to kBJlh, 
whereas it varies exponentially with -AH°*/RTf the term kBJ/h may be 
regarded as constant. Therefore the equation can be expressed:
In k =  [\n(kBJ/h) + AS°*/R] - AH°*/R . (1/T)
This shows that under these assumptions the natural logarithm of the 
rate constant is a linear function of the reciprocal of the absolute 
temperature.
The natural logarithm of each rate constant was plotted against the 
reciprocal of the appropriate inactivation temperature (in degrees Kelvin) to 
produce a straight line (An Arrhenius plot). This plot is shown in Figure 
3.6a, while Figure 3.6b shows for comparison similar data obtained in our 
laboratory for the citrate synthases of Sulfolobus solfataricus, 
Thermoplasma acidophilum and pig heart (unpublished data).
Inactivations were carried out at 64°C in 20 mM Tris-HCI (pH 8.0), 2 
mM EDTA containing 1.0,1.6,1.7,1.8, 2.0, 2.2 and 3.0 M KCI, to 
investigate the effect of KCI concentration on the thermostability of the 
enzyme. The rate constants of inactivation were determined as above and 
the combined data are plotted in Figure 3.7. Inactivation in 1.0 M KCI was 
too rapid to measure, while no inactivation was observed in the presence of 
3 M KCI.








0 .00295 0.003 0.003050 .0029
1/Temperature (Kelvin)
Figure 3.6a Arrhenius plot of thermal inactivation of citrate synthase
The graph shows In (rate constant of thermal inactivation k) plotted 
against the reciprocal of the absolute temperature in Kelvin-1. The slope of 
the graph, equal to -AH*/R, is - 117870 JK (standard error = 1960).














0 .0 0 2 6  0 .0 0 2 7  0 .0 0 2 8  0 .0 0 2 9  0 .0 0 3 0  0 .0031
1/temperature (°K) 
i _____  l _______  i__________ i__________________________ j____
0 .0 0 3 2  0 .0033
111 97 84  72  5 0
Temperature equivalent (°C)
4 0 30
Figure 3.6b Arrhenius plot of thermal inactivation of citrate synthases
This graph compares the Arrhenius data for the Hf.volcanii citrate 
synthase with those obtained in our laboratory for citrate synthases from 
other sources (unpublished data).
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Figure 3.7 Effect of KCI concentration on thermal inactivation of 
citrate synthase at 64°C
The graph shows In (% initial activity) plotted against time in minutes 
for a range of KCI concentrations.
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3.5 Discussion
At 30-40°C Hf.volcanii grows optimally at 1.7-2.5 M NaCI, with a 
minimum requirement of about 1.0 M NaCI (Mullakhanbhai & Larsen,
1975). Its internal KCI concentration is likely to fall into a similar range. The 
data show that citrate synthase is active at KCI and NaCI concentrations 
significantly below this range; approximately 50% of the activity observed 
at 2 M NaCI or KCI is retained at 0.1 M (Figure 3.1).
The activity profiles for the two cations are very similar up to a 
concentration of 1 M, at which point further increases in K+ exert no change 
on activity, while increases in Na+ give a proportional reduction in activity. 
The higher concentrations of Na+ probably induce structural changes that 
affect activity through changes in the way the enzyme binds hydrated salt 
ions. The significantly greater strength of the hydration interactions of Na+ 
over those of K+ may contribute to this. The absence of high-salt 
inactivation in KCI solutions is not surprising, considering the presence 
within Hf.volcanii of high KCI concentrations in vivo.
At 25°C Hf.volcanii citrate synthase is remarkably stable at low salt 
concentrations, even considering the organism's moderate salt 
requirements. The enzyme remains stable at salt concentrations in which it 
is active, down to 0.1 M KCI. In contrast, the citrate synthase of the extreme 
halophile Halobacterium cutirubrum exhibits some activity at 0.1 M KCI but 
has a half-life of only 4 minutes at 1 M KCI (Higa & Cazzulo, 1975).
The inactivation temperatures were increased from 25°C until 
measurable inactivation rates were observed in 2 M KCI. The inactivation 
data, displayed as Arrhenius plots in Figures 3.6a and 3.6b, show that
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H f volcanii citrate synthase is stable up to approximately 60°C. This value 
is of the order expected for an organism growing at up to 45°C. The rate of 
activity loss changes uniformly with the small variation in temperature, the 
slope of the graph giving the enthalpy change involved in formation of the 
transition state from the native enzyme during the inactivation process (980 
kJ moh1 in this case, values for pig heart, Tp.acidophilum and 
S.solfataricus being 331, 364 and 635 kJ mol-1 respectively). The 
displacement of the slope along the X-axis gives an indication of 
thermostability of the enzyme relative to those of S.solfataricus, 
Tp.acidophilum and pig heart.
The slope of the Hf. volcanii citrate synthase Arrhenius plot is 
significantly greater than those of the enzymes from pig heart or 
Tp.acidophilum. It is thought that the enthalpy change required to go from 
the native protein to the transition state is related to the breaking of 
electrostatic interactions, while the entropy change is related to the 
disruption of hydrophobic interactions. This suggests that heat denaturation 
of the Hf. volcanii enzyme requires more electrostatic interactions to be 
broken in reaching the transition state than in the others. It may be that 
surface and internal electrostatic interactions make a greater contribution to 
thermostability in the halphilic enzyme than in the pig heart or 
Tp.acidophilum enzymes..
At 2 M KCI and 66°C the rate constant of inactivation of the 
Hf. volcanii citrate synthase is 0.23 min"1, while at 3 M KCI and 40°C the 
rate constant of inactivation of the H.cutirubrum citrate synthase is 0.35 
min-1 (Higa & Cazzulo, 1975). Thus the Hf. volcanii enzyme is much more 
stable at high salt concentrations as well as at low salt concentrations.
Chapter Three Page 62
Once measurable rates of inactivation had been achieved, the effect 
of KCI concentration on stability was investigated. The data in Figure 3.7 
indicate that stability is highly dependent on KCI concentration between 1.6 
and 3 M. Figure 3.8 displays the same data, relating half-life to salt 
concentration. It is possible that at high salt concentrations (> 3 M)
Hf. volcanii citrate synthase is more thermostable than would be expected 
(i.e. remaining stable for periods of hours at temperatures more than 20°C 
above the parent organism's maximum growth temperature); however, this 
was not investigated. It is interesting to note that an increased requirement 
for NaCI has been observed when the growth temperature of Hf. volcanii is 
raised (Mullakhanbhai & Larsen, 1975).
Once Hf. volcanii citrate synthase is over-expressed in either a 
mesophilic or halophilic host, it will be necessary to compare its physico­
chemical characteristics with those of the wild-type enzyme. This 
comparison must cover both its kinetic parameters and its salt requirements 
for stability and activity. Techniques such as differential scanning 
calorimetry, to determine AG of stability, coupled with circular dichroism or 
fluorescence to measure unfolding, are required for a detailed analysis of 
enzyme stability. The methods described above are limited in that they rely 
upon enzyme activity as a measure of unfolding; however, they could 
provide a simple means of investigating the salt requirements of over­
expressed halophilic citrate synthases.
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Figure 3.8 Effect of KCI concentration on the half-life of citrate 
synthase at 64°C
The graph shows half-life in miutes plotted against KCI concentration 
(Molar).
Chapter Three Page 64
Chapter
Creation of size-restricted genomic libraries and screening 
for the citrate synthase gene
4.1 Introduction
Citrate synthase from Hf. volcanii was purified in our laboratory by Dr. 
M.J. Bonete, University of Alicante, Spain using a scheme based on that 
used to purify the H.halobium citrate synthase (James, 1990). SDS-PAGE 
of the purified enzyme revealed the presence of two major protein bands of 
apparent molecular weight 45 kD and 55 kD. These were Western blotted 
onto Immobilon P membrane and both bands were cut out and sequenced 
directly from the membrane.
Sequences were obtained for both bands. These are shown below, 
using single letter amino acid codes where X indicates an unknown residue 
and residues in parentheses are tentative assignments.
55 kD XXXXVIAAAYRTPFGKAA 
45 kD (S)GELKRGLEGVLVAESKLSFIDGDAGQLVYXGYDIEDL
The 45 kD band appears to be citrate synthase as judged by a 
SWISSPROT database search and sequence alignment described in the 
Appendix. Outlines of the purification scheme, blotting and sequencing are 
also given in the Appendix.
From the N-terminal peptide sequence of the protein, oligonucleotide 
probes were designed and used to screen Southern blots of restriction 
digested genomic DNA. A suitable size range of positively-hybridising 
fragments were identified and used to create a size-restricted genomic 
library in the pUC18 plasmid vector. This was in turn screened by 
hybridisation and positive clones were further analysed by restriction 
digests and sequencing of the plasmid DNA.
4.2 Oligonucletide design
Oligonucleotides were designed from the N-terminal sequence with a 
bias towards G and C at the third base of each codon, reflecting the high 
G+C content of the Hf. volcanii genome. In order to aid selection of third 
bases a composite codon usage table was compiled from the 
dihydrolipoamide dehyrogenase (Vettakkorumakankav etai., 1992), 
dihydrofolate reductase (Zusman et al., 1989), his C (Conover & Doolittle, 
1990) and trp cluster (Lam et al,. 1990) genes of Hf.volcanii. Figure 4.1 
summarises this information.
4.3 Southern blot analysis
Initially 10 pg aliquots of genomic DNA were digested with single 
restriction enzymes. Once restriction fragments were separated by agarose 
gel electrophoresis and immobilised on nylon membranes by Southern 
transfer, hybridisation to a y 32P end-labelled oligonucleotide was carried 
out. The sizes of hybridising fragments were calculated from 
autoradiographs of the blots.











T  TTA CTT CTA ATT ATA GTT GTA 

















TAT TAA CAT CAA AAT AAA GAT GAA
TAC TAG CAC CAG AAC AAG GACGAG 
Codon
Figure 4.1 Codon preference in Hf.volcanii
The frequency of each codon is expressed as a percentage of the 
total number coding for a particular amino acid.
































TGT TGA CGT CGA AGT AGA GGT GGA












TCT TCA CCT CCA ACT ACA GCT GCA 
TCCTCG CCCCCG ACC ACG GCCGCG
Codon
Figure 4.1 Codon preference in Hf.volcanii (continued)
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The process was repeated for genomic DNA digested with pairs of 
restriction enzymes in order to identify hybridising fragments smaller than 
those produced by single enzymes ie. fragments that were doubly digested.
4.4 Creation of a size-restricted genomic library
Approximately 150 pg genomic DNA was digested with the required 
pair of restriction enzymes and the fragments were separated on a 1 % 
agarose gel. A gel slice containing fragments of approximately the desired 
size was cut and the DNA recovered by freeze-squeeze. The fragments 
were purified using a NENsorb cartridge.
A 100 ng aliquot of commercially prepared pUC18 EcoRI /  BAP 
plasmid (ie. digested with EcoRI and treated with alkaline phosphatase) 
was digested with Psfl and purified using a NENsorb cartridge. Ligations 
were set up using 10 ng plasmid DNA with 10%, 1% and 0.1% of the 
purified fragments, each in a volume of 20 pi.
Competent E.coli JM103 were prepared by the calcium chloride 
method and a 200 pi volume transformed with 8 pi ligated DNA. 
Transformants were selected by plating out on 2xYT agar containing 
ampicillin (100 pg m M ).
4.5 Screening for positive clones
Transformants were streaked onto gridded 2xYT agar plates 
containing ampicillin (100 pg m M ). From these master plates 
transformants were streaked onto gridded nylon membranes which were 
treated as described in section 2.3.9.3 Colony Hybridisation. Positive 
clones were purified by plating out and screening single colonies by
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streaking onto gridded membranes and hybridising as above. This was 
repeated until aii the colonies screened gave a positive signal. Clones were 
stored as glycerol stocks at -20°C.
4.6 Results
4.6.1 Screening Southern blots with a non-degenerate 44 base
oligonucleotide probe
Figure 4.2 shows the sequence of a 44 base oligonucleotide 
designed from the citrate synthase N-terminal sequence. Its estimated Tm 
is in excess of 100°C (using the formula Tm = 4(Number of G and C bases) 
+ 2(Number of A and T bases)).
When used to probe a Southern blot of the restriction digests shown 
in Figure 4.3a, a Psfl fragment of approximately 7.2 kb and a Psfl /EcoRI 
fragment of approximately 2.9 kb were identified as shown in Figure 4.3b 
(lanes 2 and 5 respectively). Hybridisations and washes were carried out at 
60°C.
A library of Psfl /  EcoRI fragments in the 3 kb size range were cloned 
into p(JC18 as described in Section 5.4. Ligation of inserts into the cut 
vector yielded 534 transformants. Control transformations with ligations 
containing vector plus insert (no ligase), vector only (plus ligase) and insert 
only (plus ligase) yielded a total of 4 transformants between them. A control 
transformation with 1ng of uncut pUC18 gave an estimated transformation 
efficiency of 1.5 x 10? pg_1.
Chapter Four Page 70
Chapter Four
V A E S K L S F I D G D A G Q
GTA GCA GAA TCA AAA CTA TCA TTT ATA GAT GGA GAT GCA GGA CAA
G G G G G G G C C C G C G G G
C C C C C T C C C
T T T T T T T T
AGC TTA AGC
T G T
GTC GCC GAC TCG AAG CTT TCG TTC ATC GAC GGC GAC GCC GGC CA
Figure 4.2 Sequence of 44 base oligonucleotide probe
The citrate synthase N-terminal sequence is shown, with all possible codons below each residue. The 











Figure 4.3a Electrophoresis of genomic DNA restriction digests on 
0.6% agarose gel
Lane 1: XHind\\\
Lane 2: Psfl 
Lane 3: Smal 
Lane 4: BamHI 
Lane 5: Psfl / EcoRI 
Lane 6: Psfl / BamHI
Fragment sizes are indicated in kilobases. Figure 4.3b shows an 
autoradiograph of the corresponding Southern blot.
Lane 7: Psfl / Smal 
Lane 8: Smal / EcoRI 
Lane 9: Smal / BamHI 
Lane 10: BamHI / EcoRI
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Figure 4.3b Autoradiograph of Southern blot probed with non 
degenerate 44 base oligonucleotide (4 day exposure)
Lane 1: Not shown Lane 7: Psfl / Smal
Lane 2: Psfl Lane 8: Smal / EcoRI
Lane 3: Smal Lane 9: Smal / BamHI
Lane 4: BamHI Lane 10: BamHI / EcoRI
Lane 5: Psfl / EcoRI
Lane 6: Psfl / BamHI
The blot was washed at 60°C. Fragment sizes are indicated in
kilobases. Figure 4.3a shows the corresponding agarose gel.
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The transformants were screened by colony hybridisation as 
described above, using the same 44 base oligonucleotide. Hybridisations 
and washes were carried out at 60°C. Four strongly hybridising clones were 
indentified, plus ten that hybridised less strongly. Examples of each are 
shown in Figure 4.4.
All twelve positive clones were purified as described in Section 5.5, 
using the same hybridisation and washing conditions as the initial 
screening. After the first round of purification it became apparent that only 
the four strongly hybridising clones were true positives, as the others did 
not demonstrate reproducible hybridisation. Plasmid DNA was prepared 
from the four positive clones by the caesium chloride 'Maxiprep' method.
4.6.2 Restriction and hybridisation analysis of positive clones
Initially a dot-blot of 1 pg DNA from each positive clone was prepared, 
together with 1 pg pUC18 DNA as a control. This was probed with the 44 
base oligonucleotide, hybridising and washing at 60°C in 2xSSC. 
Hybridisation to the plasmids containing the insert was observed, while 
there was no detectable hybridisation to pUC18 alone. Restriction digests 
were carried out using the enzymes Psfl, EcoRI, H/ndlll and Aval. All of the 
positive clones appeared to contain the same insert, as judged by the 
restriction pattern.
Figure 4.5a shows the restriction fragments of one positive clone 
separated by agarose gel electrophoresis. These were transferred to nylon 
membrane by Southern blotting and probed with the 44 base 
oligonucleotide (Figure 4.5b).
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Figure 4.4 Autoradiograph of colony blot probed with 44 base non­
degenerate oligonucleotide (2 day exposure): screening 
transformants
A: Strong hybridisation (true positive)
B: Weaker hybridisation (later identified as false positive)
The blot was washed at 60°C.
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Further restriction digests were carried out the enzymes Acc\, Ava\ 
and H/ndlll. In Figure 4.6a the restriction fragments are shown, separated 
by agarose gel electrophoresis. Figure 4.6b shows a Southern blot of those 
fragments, probed with the 44 base oligonucleotide.
From these data an initial restriction map was drawn (Figure 4.7), 
although the exact binding site of the probe cannot be deduced. Fragments 
of the 2.9 kb insert were therefore sub-cloned into pUC18 for a more 
detailed analysis.
4.6.3 Sub-cloning fragments from the 2.9kb positive clone
Aliquots of 5 pg plasmid DNA were digested with Aval and HindlW. A
1.5 kb Aval fragment, 1.5 kb Hin6\\\ fragment and 1.2 kb H/ndlll fragment 
were gel purified and cleaned by passing through a NENsorb cartridge. 
Vector was prepared by digesting 1 pg aliquots of pUC18 DNA with either 
Aval or /-//ndIII, treating with alkaline phosphatase and cleaning using a 
NENsorb cartridge. Each of the fragments was ligated into appropriately cut 
vector.
Sub-clones of the two H/ndlll fragments were obtained. The Aval 
fragment proved difficult to clone, and despite several attempts no 
transformants were obtained. Since the only sub-fragment of the 2.9 kb 
clone to retain full hybridisation is that produced by Aval digestion, cloning 
and sequencing this fragment is particularly important with regard to 
locating the hybridisation site of the probe.
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Figure 4.5a Electrophoresis of restriction digests of 2.9 kb Psfl I
EcoR\ clone on 1% agarose gel
Lane 1: X HintiUl
Lane 2: Ava\ Fragment sizes: (3.7), 1.5 kb
Lane 3: H/ndlll (2.7), 1.5, 1.2 kb
Lane 4: Psfl / EcoRI 2.9, (2.7) kb
Lane 5: pUC18 EcoRI (2.7) kb
Lane 6: X Psfl
Restriction fragment sizes are indicated in kilobases (the fragment 
containing the pUC18 vector in parentheses).
Figure 4.5b shows the corresponding autoradiograph.
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Figure 4.5b Autoradiograph of Southern blot probed with 44 base 
non-degenerate oligonucleotide (4 day exposure)
Lane 1: X H/ndlll 
Lane 2: Ava\
Lane 3: H/ndlll 
Lane 4: Psfl / EcoRI 
Lane 5: pUC18 EcoRI 
Lane 6: X Psfl
Restriction fragment sizes are indicated in kilobases. Figure 4.5a 
shows the corresponding agarose gel. The blot was washed at 60°C.
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Figure 4.6a Electrophoresis of restriction digests of 2.9 kb Psfl I
EcoRI clone on 1% agarose gel
Lane 1: X Pstl
Lane 2: Aval / H/ndlll Fragment sizes: (2.7), 1.2, 0.95 kb
Lane 3: Aval / Accl (3.3), 1.2, 0.7 kb
Lane 4: >4ccl (4.0), 1.2 kb
Lane 5: EcoRI (5.7) kb
Lane 6: Pstl / EcoRI (2.8) kb
Lane 7: Aval (3.8), 1.5 kb
Lane 8: H/ndlll (2.7), 1.5, 1.2 kb
Lane 9: X H/ndlll
Restriction fragment sizes are indicated in kilobases (the fragment 
containing the pUC18 vector in parentheses).Figure 4.6b shows the 
corresponding autoradiograph.
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EcoRI







Figure 4.7 Summary of initial restriction site information obtained 
from 2.9 kb Psfl I EcoRI clone in p(JC18
No sites within the clone could be mapped unambiguously at this 
stage. In addition to the H/ndlll sites are: a pair of Aval sites 1.5 kb apart 
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4.6.4 Restriction analysis of sub-cloned H/ndlll fragments
Both the cloned 1.5 kb and 1.2 kb H/ndlll fragments were digested 
with H/ndlll, Aval and Accl. Figures 4.8 and 4.9 show the restriction 
fragments separated by agarose gel electrophoresis.
4.6.5 Sequence analysis of 2.9 kb Psfl / EcoRI clone and H/ndlll
sub-clones
In order to orientate the two H/ndlll sub-clones and to make an initial 
search for citrate synthase sequence, the ends of the 2.9 kb Psfl /  EcoRI 
clone and H/ndlll subclones were sequenced, initially using the Forward 
and Reverse universal primers of pUC18 and then using synthetic 17 base 
primers to extend the sequenced region. The locations of the regions 
sequenced are shown in Figure 4.10, which also indicates the deduced 
orientations of the subclones.
The sequences determined were translated in all reading frames 
(including those for the complementary strand) and used to search the 
Swissprot protein database via the FASTA program from the GCG 
package. The translated sequences did not show any significant identity 
with citrate synthase, although a putative open reading frame of an 
unrelated gene was identified. This open reading frame was sequenced 
and is described in more detail in Chapter 7.
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Figure 4.8 Electrophoresis of restriction digests of 2.9 kb Psfl / EcoRI
clone and H/ndlll subclones on 1% agarose gel
Lane 1: 1.5 kb H/ndlll subclone: H/ndlll digest (2.7), 1.5 kb
Lane 2: 1.5 kb H/ndll subclone: H/ndlll / Ava\ digest (2.7), 0.95, 0.3 kb
Lane 3: 1.2 kb H/ndlll subclone: H/ndlll digest (2.7), 1.2 kb
Lane 4: 1.2 kb H/ndlll subclone: H/ndlll / Ava\ digest (2.7), 1.2 kb
Lane 5: 2.9 kb Pst\ / EcoRI clone: H/ndlll digest (2.7), 1.5, 1.2 kb
Lane 6: 2.9 kb Psfl / EcoRI clone: H/ndlll / Ava\ digest (2.7), 1.2, 0.95, 0.3 kb
Lane 7: X Psfl
Restriction fragment sizes are indicated in kilobases (the fragment
containing the pUC18 vector in parentheses).
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Figure 4.9 Electrophoresis of restriction digests of 2.9 kb Pstl I EcoRI
clone and 1.5 kb H/ndlll subclone on 2% agarose gel
Lane 1: Low range DNA markers
Lane 2: 2.9 kb Psfl / EcoRI clone: H/ndlll digest (2.7), 1.5, 1.2 kb
Lane 3: 2.9 kb Psfl / EcoRI clone: H/ndlll / Ava\ digest (2.7), 1.2, 0.95, 0.32 kb
Lane 4: 1.5 kb H/ndlll subclone: H/ndlll digest (2.7), 1.5 kb
Lane 5: 1.5 kb H/ndlll subclone: Aval digest (3.3), 0.35, 0.3
Lane 6: 1.5 kb H/ndlll subclone: H/ndlll 1 Aval digest (2.7), 0.95, 0.32
Lane 7: X Pstl
Restriction fragment sizes are indicated in kilobases (the fragment
containing the pUC18 vector in parentheses).




















Figure 4.10 Regions of 2.9 kb Psfl I EcoRI clone and H/ndlll subclone 
sequenced.
Distances are indicated in kilobases. X, Y and Z indicate the 
orientation of the /-//ndlll fragments.
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The sequence data (including that presented in Chapter 7) are 
combined with the results of the restriction digests described above to give 
the restriction maps shown in Figure 4.11.
4.7 Screening with a pair of degenerate 17 base oligonucleotide
probes
As a unique 44 base oligonucleotide had failed to identify a citrate 
synthase gene, a different approach was taken in designing new 
oligonucleotides from the citrate synthase N-terminal sequence. 
Furthermore, as the long oligonucleotide appeared to bind to an unrelated 
gene, it was necessary to consider the possibilty that other oligonucleotides 
designed to the same stretch of amino acid sequence also bind to that 
gene.
A pair of non-overlapping, degenerate 17 base oligonucleotides 
(referred to here as A and B) were designed to the citrate synthase N- 
terminal sequence as shown in Figure 4.12. Their Tms were estimated as 
46-56°C for oligonucleotide A and 40-52°C for oligonucleotide B, using the 
formula described for the 44 base probe.
These were used as probes with the aim of identifying a restriction 
fragment to which both would bind independently. Ideally the two non- 
overlapping regions of sequence used would not include the region of 
sequence used to design the previous 44 base probe, in order to minimise 
the risk of hybridisation to the unrelated gene described in Chapter 7.
In a degenerate oligonucleotide mixture the number of different 
species must be kept below the limit where the "correct" sequence is 
present in such a small proportion as to be undetectable. It was therefore
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Figure 4.11 Restriction map of 2.9 kb Pstl I EcroRI clone
This map was compiled from restriction digest and sequence data. 
The restriction sites in parentheses were not confirmed by sequencing. 
Distances are indicated in kilobases.




V A E S K L S F I D G D A G Q L V  Y X G Y D I E D L
GTA GCA GAA TCA AAA CTA TCA TTT ATA GAC GGA GAC GCA GGA CAA TAC GAC ATA GAA GAC CTA
G G G G G G G C C T G T G G G T T C G T G
C C C C C T C C C T C
T T T T T T T T T
AGC TTA AGC TTA
T G T G
GTC GCC GAC TCG AAG CTT TCG TTC ATC GAC GGC GAC GCC GGC CA
Probe A: TTC ATA GAC GGA GAC GC Probe B: TAC GAC ATA GAA GAC CT




Figure 4.12 Sequence of 17 base oligonucleotide probes
The citrate synthase N-terminal sequence is shown, with all possible codons below each residue. The 
probe sequences are shown in bold, including degeneracies. The 44 base probe is also shown.
decided to limit the number of possible sequences for each oligonucleotide 
to a maximum of 96. To avoid exceeding this limit, one of the two 
oligonucleotides (oligo A) had to be made to a region overlapping that used 
to design the 44 base probe.
4.7.1 Preliminary dot-blot results
Initial hybridisations were carried out with both 17mers to dot-blots of 
1 pg of the 2.9 kb Pst\ / EcoRI clone and 1 pg genomic DNA to confirm that 
they hybridised to genomic DNA and not to the previously-cloned open 
reading frame. Both probes were found to hybridise to genomic DNA at 
30°C, while neither hybridised to the 2.9 kb Psfl /  EcoRI clone at this 
temperature. Oligonucleotide A hybridised more strongly than B, as judged 
by the intensity of the dots. In both cases hybridisation was poor, dots only 
becoming visible after a 14-day exposure.
4.7.2 Southern blot results
Hybridisation of oligonucleotide B was carried out at 30°C to 
Southern blots of genomic DNA digested with single restriction enzymes. 
After washing the blots at 30°C, autoradiographs showed that this probe 
was not hybridising under these conditions. This probe was not considered 
suitable for further investigation.
Oligonucleotide A was hybridised to Southern blots of genomic DNA 
digested with both single restriction enzymes and with pairs of enzymes. 
Initial blots were hybridised and washed at 37°C. Figures 4.13a and b show 
an example set of restriction digests and corresponding Southern
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Figure 4.13a Electrophoresis of genomic DNA restriction digests on 
0.6% agarose gel
Lane 1: A. H/ndlll 
Lane 2: H/ndlll / Psfl 
Lane 3: H/ndlll / Sph\
Lane 4: H/ndlll / Sa/I 
Lane 5: Psfl / Sa/I 
Lane 6: SpHI / Psfl
Fragment sizes are indicated in kilobases. Figure 4.13b shows an 
autoradiograph of the corresponding Southern blot.
Lane 7: Sph\ / Sa/I 
Lane 8: H/ndlll 
Lane 9: Sph\
Lane 10: A. Psfl
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Figure 4.13b Autoradiograph of Southern blot probed with 
degenerate 17 base oligonucleotide A (9 day exposure)
Lane 1: X H/ndlll Lane 7: Sphl / Sa/I
Lane 2: H/ndlll / Psfl Lane 8: H/ndlll
Lane 3: H/ndlll / Sphl Lane 9: Sphl
Lane 4: H/ndlll / Sa/I Lane 10: A. Psfl
Lane 5: Psfl / Sa/I
Lane 6: Sphl / Pstl
Fragment sizes are indicated in kilobases. Figure 4.13a shows the 
corresponding agarose gel. The blot was washed at 37°C, in 2x SSC.
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blot; hybridisation to a number of bands in each lane is apparent 
(autoradiograph exposed for 9 days).
As only one of the pair of probes (oligonucleotide A) exhibited 
potentially useful hybridisation, the possibility of two independent 
identifications of a restriction fragment containing the citrate synthase gene 
N-terminus was no longer viable. This meant that either such a fragment 
would have to be unambiguously indentified from the hybridisation of the 
remaining 17mer (ie. single bands would have to be identified on a 
Southern blot), or a new probe would have to be designed.
Before taking the step of involving new probes, the possibility of 
identifying single restriction fragments using oligonucleotide A alone was 
investigated.
In order to eliminate non-specific hybridisation and to obtain single 
bands in each lane, further blots were hybridised and washed at 42°C. 
Figures 4.14a and 4.14b show the result obtained under these conditions 
(autoradiograph exposed for 17 days). As multiple bands were still visible 
under these conditions, the stringencies of the hybridisation and wash were 
increased by raising the temperature of both to 45°C. This resulted in a 
further decrease in the intensity of all bands visible on the previous 
autoradiographs, without enhancement of any particular band.
In another approach to improving specificity, hybridisations were 
carried out at 37°C, where the oligonucleotide was known to bind 
efficiently, followed by washes where salt concentrations had been reduced 
to increase the stringency. These washes were at 37°C, in the same 
solution as describe in Section 2.3.9.1, except that the concentration of 
SSC was reduced from 2x to 0.5x. Figures 4.15a and 4.15b show that
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Figure 4.14a Electrophoresis of genomic DNA restriction digests on 
0.6% agarose gel
Lane 1: X H/ndlll Lane 1 Smal / EcoRI
Lane 2: H/ndlll / Sphl Lane i5: Smal /BamHI
Lane 3: H/ndlll / Sa/I Lane S): BamHI / EcoRI
Lane 4: Psfl / Sa/l 
Lane 5: Sphl / Sa/I 
Lane 6: Sphl / Psfl
Fragment sizes are indicated in kilobases. Figure 4.14b shows an 
autoradiograph of the corresponding Southern blot.
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Figure 4.14b Autoradiograph of Southern blot probed with 
degenerate 17 base oligonucleotide A (17 day exposure)
Lane 1: X H/ndlll Lane 7: Smal / EcoRI
Lane 2: H/ndlll / Sph\ Lane 8: Smal /  BamHI
Lane 3: H/ndlll / Sa/I Lane 9: BamHI / EcoRI
Lane 4: Psfl / Sa/I 
Lane 5: Sp/?l / Sa/I 
Lane 6: Sp/?l / Psfl
Fragment sizes are indicated in kilobases. Figure 4.14a shows the 
corresponding agarose gel. The blot was washed at 42°C, in 2x SSC.
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P
Figure 4.15a Electrophoresis of genomic DNA restriction digests on 
0.6% agarose gel
Lane 1: X H/ndlll 
Lane 2: H/ndlll / Sph\
Lane 3: H/ndlll / Sa/I 
Lane 4: Psfl / Sa/I 
Lane 5: Spfrl / Psfl 
Lane 6: Spf?l / Sa/I
Fragment sizes are indicated in kilobases. Figure 4.15b shows an 
autoradiograph of the corresponding Southern blot.
Lane 7: Smal / EcoRI 
Lane 8: Smal /  BamHI 
Lane 9: BamHI / EcoRI
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Figure 4.15b Autoradiograph of Southern blot probed with 
degenerate 17 base oligonucleotide A (30 day exposure)
Lane 4: Psfl / Sa/I 
Lane 5: Sph\ / Sa/I 
Lane 6: Sph\ / Psfl
Fragment sizes are indicated in kilobases. Figure 4.15a shows the 
corresponding agarose gel. The blot was washed at 37°C in 0.5x SSC.
Lane 1: X H/ndlll 
Lane 2: H/ndlll / Sph\ 
Lane 3: H/ndlll / Sa/I
Lane 7: Smal / EcoRI 
Lane 8: Smal /  BamHI 
Lane 9: BamHI / EcoRI
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these conditions did not improve the hybridisation specificity 
(autoradiograph exposed for 30 days).
As a single hybridising restriction fragment could not be identified 
using oligonucleotide A alone, a further oligonucleotide was designed as 
described below.
4.8 Screening Southern blots with a non-degenerate 29 base
oligonucleotide probe
A 29 base non-degenerate oligonucleotide was designed to the 
citrate synthase N-terminal sequence, with reference to the codon usage 
data previously described in Figure 4.1. It's predicted melting temperature 
is 102°C. The new sequence did not overlap the previous 44 base 
oligonucleotide and is shown in Figure 4.16.
The non-degenerate design approach was taken for two reasons: the 
difficulties already encountered when using degenerate oligonucleotides as 
probes and the lack of suitable regions to design further degenerate 
oligonucleotides.
The new oligonucleotide was made shorter than the previous 44 
base non-degenerate probe to reduce the possibility of hybridisation to 
sequences other than the citrate synthase gene. The 44 base probe may 
have been excessively long, contributing to its ability to hybridise to an 
unrelated gene.
4.8.1 Preliminary dot-blot results
The 29 base probe was observed to hybridise to dot-blots of 1 pg 
genomic DNA when hybridisation and washing were carried out at 55°C.




L V A E S K L S F I D G D A G Q L V Y X G Y D I E D L
GGA GCA CTA AAA CGA GGA CTA GCA GGA GTA
G G G G G G G G G G
C C C C C C C C C
T T T T T T T T T
TTA AGA TTA
G G G
GGC GAG CTC AAG CGC GGC CTC GAG GGC GT
Figure 4.16 Sequence of 29 base oligonucleotide probe
The citrate synthase N-terminal sequence is shown, with all possible codons below each residue. The 
probe sequence is shown in bold.
4.8.2 Southern blot results
Hybridisation was carried out at 55°C to Southern blots of genomic 
DNA digested with single restriction enzymes. Washing was also carried 
out at 55°C. Figures 4.17a and 4.17b show the result (autoradiograph 
exposed for 30 days). The majority of the probe hybridised to high 
molecular weight restriction fragments or undigested DNA. Smaller 
hybridising fragments are visible, notably a 4 kb EcoRI fragment (Figure 
4.17a, lane 7).
As it was necessary to expose each autoradiograph for a long period 
(30 days) it was considered impractical to use the Southern blotting 
technique to follow up this result in a reasonable timescale. At these 
hybridisation and washing stringencies, exposure times were prohibitively 
long, while use of less stringent conditions would run the risk of introducing 
non-specific hybridisation without greatly decreasing the necessary 
exposure time.
From this point onwards the 29 base oligonucleotide was applied as 
a PCR primer as described in Chapter 6. This technique had the potential 
to be optimised in a much shorter time.
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Figure 4.17b Autoradiograph of Southern blot probed with non­
degenerate 29 base oligonucleotide (30 day exposure)
Lane 1: X H/ndlll Lane 7: EcoRI
Lane 2: H/'ndlll Lane 8: Sa/I
Lane 3: Psfl Lane 9: Kpn\
Lane 4: Sph\ Lane 10: X Psfl
Lane 5: Smal
Lane 6: BamHI
Fragment sizes are indicated in kilobases. Figure 4.17a shows the 
corresponding agarose gel. The blot was washed at 55°C, in 2x SSC.
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4.9 Discussion
This chapter describes the hybridisation results obtained with two 
different types of oligonucleotide probe designed to an N-terminal peptide 
sequence: long, non-degenerate probes designed with reference to codon 
usage and shorter, degenerate probes incorporating all possible sequences 
in the synthetic mixture. The former relies on its length to give specificity, 
under the assumption that the percentage of mis-matches in its sequence 
will be low and hybridisation will occur despite their presence. An accurate 
estimate of codon usage is a pre-requisite. This approach has the 
advantage that if the probe is a good match, all of the oligonucleotide 
molecules have the potential to hybridise to the target, as they all have the 
same sequence.
The latter approach relies on the use of a probe mixture containing 
all possible sequences, thereby guaranteeing that some are perfect 
matches to the target. However, only a small percentage of the molecules 
have the potential to hybridise, reducing the maximum signal that it is 
possible to obtain.
The 44 base probe hybridises to a non-citrate synthase sequence, a 
problem that may have been avoided by the use of a shorter 
oligonucleotide (Figure 4.18). The hybridisation data in Figure 4.5b shows 
that the binding site of the probe lies within the 1.5 kb Aval fragment. When 
this fragment is cut with H/ndlll the strong hybridisation is lost and a small, 
weakly hybridising Aval / H/ndlll is released. This fragment is visible in 
Figure 4.6b (lane 2). From the sequencing data this fragment is 310 base 
pairs in length.
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Figure 4.18 Possible probe binding sites within 2.9 kb Psfl / EcoRI 
clone
All distances are in kilobases. X, Y and Z indicate the positions of the 
sites. Their sequences, including identity with the probe, are shown below 
(the probe would hybridise to the complementary strand):
X (24/44 matches):
870
O R F : ATCGAACTCGCGGAGTCAGCGACCATCGAAGACGGCGCAGTCGT*★★ ★ ** *★ ★* •* ★★ **★ ★ *
P r o b e : GTCGCCGACTCGAAGCTTTCGTTCATCGACGGCGACGCCGGCCA
Y (25/44 matches):
687
O R F : ATCACGGACGCGATTCAGTCACTCCTCGAAGACGGCTACGCCAT
★  *  *  * * • * ■  *  *  ■*■ *  * ★  * *  *  ★  *  *  ★ *  *
P r o b e : GTCGCCGACTCGAAGCTTTCGTTCATCGACGGCGACGCCGGCCA
Z (24/44 matches):
507
O R F : GTCGAGAACCCACAGCAGTTCGGCATTGCGGACGTCGACGACCA
★  -k  *  ★  *  *  *  ★  ★  ★  ★  ★  *  *  ★
P r o b e : GTCGCCGACTCGAAGCTTTCGTTCATCGACGGCGACGCCGGCCA
H/ndlll fragment AB hybridises weakly Ava\ fragment GH hybridises strongly
Hin4\\\IAva\ fragment CD hybridises weakly Pst\/EcoR\ fragment IJ hybridises strongly 
Acc\ fragment EF fragment hybridises weakly H/ndlll fragment KL does not hybridise
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subclones were sequenced such that the presence of a citrate synthase 
gene could be discounted.
The second approach used to locate the citrate synthase gene used mixed 
pools of probes. It is difficult to predict hybridisation conditions for mixed 
sequences as their Tm values vary considerably within the pool. Initial 
experiments were therefore carried out using hybridisation and washing 
temperatures below the lowest predicted Tm and the stringency of 
subsequent experiments was gradually increased.
If the perfectly-matched probe has a Tm in the lower part of the 
pool's Tm range it is unlikely that its specific hybridisation will be retained 
after all the non-specifically hybridised probes have been washed off. This 
effect may have contributed to the poor hybridisation results obtained with 
the pair of 17 base probes. The long exposure times required could suggest 
inefficient end-labelling of the probe, although approximately 40% or more 
of the oligonucleotides were labelled in all cases. Normally one would 
expect about 50% of the oligonucleotides to be labelled. Efforts were made 
to increase incorporation by re-cleaning the oligonucleotide solutions by 
ethanol precipitation, increasing the molar excess of ATP over 
oligonucleotides and using fresh reagents; however no improvement in 
incorporation was observed.
The second non-degenerate oligonucleotide was designed with 
reference to the results obtained for the 44 base probe. For the reasons 
described above, it was made shorter than the previous non-degenerate 
probe and to a different region of the N-terminal sequence. There was no 
reason from previous observations to suggest that a second attempt at this 
approach to probe design would be unsuccessful, provided that these 
changes were made. Despite reasonable levels of ATP incorporation when
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end-labelling (approximately 40% of the oligonucleotides labelled), 
autoradiograph exposure times were very long. Although the hybridisation 
appeared to be fairly specific, analysis of further Southern blots and 
screening of cloned restriction fragments under these conditons would be 
very time consuming. Subsequent cloning strategies were centred around a 
PCR approach as this appeared to offer a more efficient way forward for 
the project.
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Chapter ^
Affinity purification of citrate synthase and determination 
of internal peptide sequence
5.1 Introduction
It is clear from the results presented in Chapter 4 that the 
identification of a genomic fragment containing the citrate synthase gene 
by hybridisation to oligonucleotides designed from the N-terminal amino 
acid sequence met with limited success. Knowledge of a suitable internal 
peptide sequence would therefore be highly valuable as it provides the 
opportunity to attempt PCR amplification using primers designed entirely 
from peptide sequences. An oligonucleotide can be designed from its 
corresponding peptide sequence with far greater confidence than is 
possible when designing a consensus probe from a multiple sequence 
alignment. The chance of successful PCR amplification is greatly 
enhanced when using such oligonucleotides as primers. The strategies 
used to design PCR primers are discussed in greater detail in Chapter 6.
Due to lack of material, re-purification of citrate synthase was 
required before further sequence analysis could be made. The original 
purification procedure gave a poor recovery of partially pure enzyme. An 
alternative was sought at this stage in an effort to improve recovery and 
purity in the final preparation.
Matrex Gel Red A is an agarose support to which the triazine dye 
ligand Procion Red HE-3B is covalently bound. The structure of Procion
Red is shown in Figure 5.1. This dye has a high affinity for NADP-iinked 
enzymes, but a lower affinity for NAD-linked enzymes. It has found 
applications in the purification of dehydrogenases where it is thought to 
bind to the nucleotide-binding site. The stuctural basis of this binding is 
unknown, although from studies on lactate dehydrogenase (Kirchberger et 
a/., 1989) it appears that the rigid conformation of the terminal rings and 
the presence of the terminal ring sulphonate groups are important. 
Coenzyme A shares structural similarities with NADP, both having an 
adenine moiety linked to a phosphorylated ribose, although the two are 
phosphorylated at different positions on the sugar.
Based on this information, studies have previously been carried out 
on the binding of the coenzyme A-linked enzymes citrate synthase and 
succinate thiokinase, from six different organisms (Weitzman & Ridley, 
1983). Significant purifications were achieved for both enzymes using a 
simple salt gradient elution.
Matrex Gel Red A has been used with success in the purification of 
citrate synthase from Acinetobacter calcoaceticus (Mitchell & Weitzman, 
1983) and Bacillus coagulans (Schendel etal.t 1992), eluting ligand-bound 
enzyme with either a salt gradient or biospecifically with oxaloacetate and 
coenzyme A. More recently the citrate synthases of a number of Archaea, 
including Sulfolubus solfataricus (James et a/., 1994) and Pyrococcus 
furiosus (Muir etal. 1994a) have also been purified using this ligand. This 
method therefore appeared to be a good candidate for purification of the 
Hf.volcanii citrate synthase. Salt gradients (0-800 mM KCI in the case of 
B.coagulans above) have been found to elute bound citrate synthase from 
Red A; however, given that halophilic citrate synthases only achieve native
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Figure 5.1 Partial structure of Matrex Gel Red A
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conformation in high salt conditions the possibility of specific binding and 
elution in high salt warranted investigation.
6.2 Outline of the purification scheme
Hf.volcanii (2 g wet weight) was resuspended in 10 ml 20 mM Tris- 
HCI (pH 8.0), 2 mM EDTA, 0.1 M KCI and a cell extract prepared by 
sonication as described in Section 2.1.1.2.
The cell extract was applied to a 10 ml column of Matrex Gel Red A 
equilibrated with the same buffer. After washing, citrate synthase was 
eluted with 1 mM oxaloacetate, 0.2 mM coenzyme A in the same buffer. 
Fractions containing citrate synthase activity were pooled and 
concentrated to a total volume of 2 ml using solid polyethylene glycol as 
described in Section 2.2.3. This method was found to give > 90% recovery 
of citrate synthase activity after concentration.
Microsep microconcentrators (10 kD cutoff) were also tried as a 
method of protein concentration but proved unsuitable as the flow rate 
through the filter decreased rapidly after the first 10 minutes of 
centrifugation, suggesting that the protein was adhering to the filter 
membrane. Only 50% of the citrate synthase activity applied to the 
concentrator could been recovered when using this method.
The concentrated solution was adjusted to 2 M KCI by addition of 
solid KCI and was then applied to an FPLC Superdex-200 gel filtration 
column equilibrated with 20 mM Tris-HCI (pH 8.0), 2 mM EDTA, 2 M KCI. 
Fractions containing citrate synthase activity were pooled, dialysed 
against 10 mM ammonium bicarbonate, 0.01% (w/v) SDS and dried in a 
Savant Speedvac concentrator.
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5.3 Cyanogen bromide cleavage
Cyanogen bromide cleavage and N-terminal sequencing were 
carried out by Mrs. Janice Young at Zeneca Pharmaceuticals,
Macclesfield. An estimated 20 |jg protein was dissolved in 250 pi 70%
(v/v) formic acid, in a polypropylene tube and 186 pi cyanogen bromide 
solution (10 mg ml-1 in 70% (v/v) formic acid) added. After purging with 
nitrogen, the sample was incubated in the dark for 24 hours, at room 
temperature.
The sample was dried, after addition of 5 pi 10% (w/v) SDS to 
prevent fragments sticking to the tube. The sample was re-dissolved in 
water and dried again to remove the acid. The sample was dissolved in 
reduced tris-tricine sample buffer, run on a 16.5% tris-tricine 
polyacrylamide minigel and blotted onto Problott membrane. A band of 
approximately 6 kD was cut out.
5.4 N-terminal sequencing
To repeat the N-terminal sequencing of the intact protein, 5-10 pg 
was dissolved in reducing sample buffer, subjected to SDS- 
polyacrylamide gel electrophoresis and blotted onto Problott membrane. 
The single band was cut out and sequenced using an Applied Biosystems 
477 Sequencer (modified to run blot cycles) with a gas phase TFA 
delivery.
The cyanogen bromide fragment was sequenced using an Applied 
Biosystems 475 Sequencer. In both cases the sequencers were coupled to 
an Applied Biosystems 120A Phenylthiohydantoin analyser.
Chapter Five Page 111
5.5 Results
5.5.1 Purification










Cell-free extract 160 13.5 0.085 1 100
Red A 0.66 10.8 16.42 196 81
PEG concentration - 10.7 - - -
Superdex-200 0.21 9.5 45.2 532 70
Figures 5.2 and 5.3 show elution profiles of the Red A column and 
Superdex-200 column respectively. Figure 5.4 shows an SDS- 
polyacrylamide gel of the cell extract, the pooled fractions from the Red A 
column and the pooled fractions from the Superdex-200 column after 
dialysis and drying.
CoA in the Red A gel fractions was assayed by addition of DTNB to 
an aliquot of the fraction, in the absence of oxaloacetate. The reaction was 
followed to completion spectrophotmetrically as for a citrate synthase 
assay and the CoA concentration calculated from the final absorbance at 
512 nm.
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Figure 5.2 Matrex gel Red A chromatography of citrate synthase
The elution profile of a 10 ml column is shown. Citrate synthase 
activity (U), total protein (mg) and Coenzyme A concentration (mM) in 
each 1 ml fraction are plotted against elution volume (ml).
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Figure 5.3 FPLC Superdex-200 gel filtration of citrate synthase
Citrate synthase activity (U) and absorbance at 280 nm are plotted 
against elution volume (ml) for each 1 ml fraction. The void volume of the 
column is 30 ml. The absorbance peak at 60 - 70 ml is caused by CoA 
eluting from the column.
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1 2 3 4 5
Figure 5.4 SDS-PAGE of citrate synthase
Lane 1: Pig heart citrate synthase 
Lane 2: Molecular weight markers 
Lane 3: Hf.volcanii cell extract 
Lane 4: Matrex gel Red A eluent 
Lane 5: Superdex-200 eluent 
Sizes are indicated in kD.
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5.5.2 N-terminal sequencing
The re-sequencing of the N-terminus of the uncleaved protein 
confirmed the 38 residue sequence previously obtained. The yield of 
fragments from cyanogen bromide treatment was unexpectedly low: on 
SDS-PAGE only a single band 6 kD band was visible. The N-terminal 
sequence of the 6 kD band was determined and is shown below. Residues 




In terms of final purity and recovery of citrate synthase the revised 
purification scheme is a significant improvement on that previously used. 
The dried citrate synthase appeared pure as judged by the appearance of 
a single band on SDS gels. The most significant loss of material occurred 
during the concentration step, where the protein appeared to bind to the 
filtration membrane.
Trials of the Red A column were carried out on small (1 ml bed 
volume) columns using a variety of different loading and elution conditions 
Initially the procedure described above was carried out in buffers 
containing 1 M KCI, the concentration at which the enzyme has maximum 
activity, since if the Red A dye is acting as nucleotide analogue it is likely
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to bind at the acetyl coenzyme A binding site and a fully active enzyme 
ensures correct conformation of that site. Under these conditions citrate 
synthase bound irreversibly to the column, resisting elution with 
concentrations of oxaloacetate and coenzyme A as high as 10 mM and 1 
mM respectively. The binding appeared to be specific as the vast majority 
of the protein loaded onto the column could be accounted for in the initial 
wash.
Reducing the KCI concentration to 0.1 M, the minimum KCI 
concentration at which the enzyme retains both activity and stability, 
resulted in modified specific binding which could be overcome by addition 
of 1 mM oxaloacetate and 0.2 mM coenzyme A as described. The 
difference in binding could be due to non-specific interactions between 
citrate synthase and the dye-ligand matrix which occur in addition to the 
specific binding, in the presence of 1 M KCI. Alternatively the change in 
binding with KCI concentration may be caused by a change in the 
enzyme's affinity for the ligand, coenzyme A or oxaloacetate.
It has since been shown in our laboratory that as the KCI 
concentration is decreased from 1 M to 0.1 M, the Km of oxaloacetate 
decreases and the Km of acetyl coenzyme A increases (Henderson, 
1994). This suggests that oxaloacetate may become a more efficient 
eluant at lower salt concentrations, where its Km is lower. If the Km of 
coenzyme A increases at lower KCI concentrations, the binding to the 
column may be weaker under these conditions.
The internal peptide sequence was aligned by hand to the same 
citrate synthase multiple sequence alignment as was used to align the N- 
temimal sequence. Figure 5.5 shows the relevant region of the alignment. 
The sequence shows very high identity with the other citrate synthases
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and includes four residues that are conserved in all the enzymes. The 
cyanogen bromide cleavage site is likely to be a methionine in the 
equivalent position to that observed in the E.coli, A.aceti, R.prowazekii, 
M.smegmatis and Tp.acidophilum sequences. These sequence data were 
used to design an oligonucleotide primer for use in PCR as described in 
Chapter 6.















































m t .emnyYTv 











































-------- T- -F R--G-
Figure 5.5 Alignment of 6kD peptide N-terminal sequence with citrate synthase multiple 
sequence alignment
Chapter
Amplification of the citrate synthase gene of Haloferax volcanii 
from genomic DNA by PCR
6.1 Introduction
The amplification of genomic DNA by the polymerase chain reaction 
provides an alternative to the Southern blot screening approach in gene 
cloning. The success of a PCR reaction relies heavily on the specificity of the 
primers used, which in turn requires careful primer design at the planning stage.
Primers may be designed with reference to a known amino acid 
sequence and codon-usage table, or alternatively an alignment of related 
protein sequences may be created and used to identify highly conserved 
regions of sequence, which are in turn used for primer design. The first method 
is far superior as it relies on only one set of assumptions (the codon-usage 
table), while the second relies on two (both the primary amino acid sequence 
and the codon use are inferred). Both of these strategies were applied in this 
project.
6.2 PCR amplification of an 830 bp sequence from genomic DNA
using N-terminal and consensus amino acid sequences for primer
design
The aim of the reactions described in this section was to amplify a large 
part of the citrate synthase gene for cloning and sequencing. From these 
sequence data a restriction map could be made and long, perfectly matched
oligonucleotide probes designed with which to screen Southern blots as 
described in Chapter Four, but with much greater efficacy.
6.2.1 Primer design
These reactions were carried out before the internal protein sequence 
data described in Chapter Five had been determined. The sense primer used 
was the non-degenerate 29 base oligonucleotide made to the citrate synthase 
N-terminal amino acid sequence (described in Figure 4.16).
The anti-sense primer was therefore made with reference to an alignment 
of citrate synthase amino acid sequences, shown in Figure 6.1. The alignment 
was created by M. McCormack, in our laboratory using the program PILEUP in 
the GCG program package. There are four particularly well conserved regions 
apparent in the alignment (designated R1 to R4 in Figure 6.1), each containing 
a number of residues conserved in ail citrate synthases so far sequenced.
The only Archaeal citrate synthase sequence available is that of 
Thermoplasma acidophilum (Sutherland et a/., 1991) which shows 19-20% 
identity with eukaryotic sequences and 27-28% with bacterial sequences. The 
citrate synthase sequences currently available show higher identity within a 
domain than between domains (Sutherland ef a/., 1991). The N-terminal 
sequence of the Hf.volcanii enzyme shows highest identity with the 
corresponding region of the E.coli enzyme (50%) and the Tp.acidophilum 
enzyme (42%). This was considered in choosing residues from the conserved 
regions of the alignment (R1 to R4) most likely to occur in the Hf.volcanii 
enzyme, as shown in Figure 6.2.
The most probable DNA sequences corresponding to these regions were 
estimated using the codon use data in Figure 4.1 and are given in Figure 6.3.










































































Chicken heart ygGmrgmkgl vyetsvldpd egi.rfrGfs ipecqkllpk gg. .... xg
Pig kidney ygGmrgmkgl vyetsvldpd egi.rfrGys ipecqkmlpk ak. .........gg
Yeast (cytoplasm) ygGmrgipgs vwegsvldpe dgi.rfrGrt iadiqkdlpk ak. .... gs
Yeast (mitoch) ygGmrgikgl vwegsvldpe egi.rfrGrt ipeiqrelpk ae. .... gs
Tetrahymena igGmrgmkgl msdlsrcdpy qgi.ifrGyt ipqlkeflpk adpkaadqan
Mycobacterium hkGlagvwd ttaiskwpe tnsltyrGyp vqd.1....
Bacillus ipGlegvias etkisfldtv nseivikGyd 11a.1 ....
Acinetobacter dpGfmatasc eskitfidgd kgillhrGyp idq.1 ....
Pseudomonas dpGfmstasc eskityidgd kgvllhrGyp ieq.1 ....
Escherichia dpGftstasc eskitfidgd egillhrGfp idq.1 ....
Acetobacter dpGygetaac nskitfidgd kgvllhrGyp iaq.1.... ..... d
Coxiella dvGfystaac eskitfidge kgillyrGyp idq.1 ....
Rickettsia dpGfmstasc qstityidgd kgilwyrGyd ikd.l....
Th ermopl a sma skGledvnik wtrlttidgn kgilrygGys vedii....

























































































Figure 6.1 Multiple sequence alignment of citrate synthases.














Th ermopl a sma 
Consensus
151____________________________ ___ •__________
lhpmsqlsaa itaLnsesnf arayaeg.il rtkywemvye 
lhpmsqlsaa itaLnsesnf arayaeg.ih rtkyweliye 
lhpmaqfsia vtaLeseskf akayaqg.is kqdywsytfe 
lhpmaqfsia vtaLeseskf akayaqg.vs kkeywsytfe 
lhsmtmlsma llyLqkdskf aklydegkis kkdywepfye
chpmdwrta isyLg  aedleedvdt aeanya....
ahpmdalrtg vsvLa  sfdtellnre hstnlk....
ahpmaimvgv vgaLs  afyhnnldie dinhrei...
ahpmavmcgv igaLs afyhdsldit npkhrqv.. .
shpmavmcgi tgaLa  afyhdsldvn nprhrei...
ahpmailcgt vgaLs  afypdandia ipanrdl...
ahpmamvlst igaLs  afyhdaldit kpadrel...
shpmaimlaa vgsLs  afypdllnfn etdy.el...
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Figure 6.1 Multiple sequence alignment of citrate synthases.
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301 •  a ,  ?350
Chicken heart lAnqevl gwL aqlqkaxxxa gadaslrdYi wntl..nsgr wpGYGHaVl
Pig kidney lAnqevlvwL tqlqkevgkd vsdeklrdYi wntl..nsgr wpGYGHaVl
Yeast (cytoplasm) rAnqevlewL falkeevndd yskdtiekYl wdtl..nsgr vipGYGHaVl
Yeast (mitoch) rAnqevlewL fklreevkgd ysketiekYl wdtl..nagr WpGYGHaVl
Tetrahymena lAnqevlkwL lqfieekgtk vsdkdiedYv dhvi..ssgr wpGYGHaVl
Mycobacteri um gAneavmhdM leig..... .saekapeWl hgklsrke.. kvmGFGHrVy
Bacillus gAneavmemL qdaq..... .tvegfkhLl hdklskke.. kimGFGHrVy
Acinetobacter gAneavlkmL deig..... .svenvaeFm ekvkrke..v klmGFGHrVy
Pseudomonas gAneavlrmL deig..... .dvsnidkFv ekakdkndpf kimGFGHrVy
Escherichia gAneaalkmL eeis..... .svkhipeFf rrakdkndsf rlmGFGHrVy
Acetobacter gAneavlkmL arig..... .kkenipaFi aqvkdknsgv kimGFGHrVy
Coxiella gAneaclnmL rkig..... .deknigqYi kkakdkndpf rlmGFGHrVy
Rickettsia gAneavinmL keig..... .ssenipkYv akakdkndpf rlmGFGHrVy
Th ermopl a sma gAaeaaiaqF deik..... .dpamvekWf nd.niingkk rlmGFGHrVy




Chicken heart rkt.DpRytc qref..... alkhlpgdpm fklvaqlyki vpnvlleqga
Pig kidney rkt.DpRytc qref...... alkhlphdpm fklvaqlyki vpnvlleqgk
Yeast (cytoplasm) rkt.DpRyma qrkf..... amdhfpdyel fklvssiyev apgvltehgk
Yeast (mitoch) rkt.DpRyta qref..... alkhfpdyel fklvstiyev apgvltkhgk
Tetrahymena rdt.DpRfhh qvdf..... skfhlkddqm ikllhqcadv ipkklltykk
Mycobacterium .kngDsRvpt mk....vale qvaqvrdgqr wldiyn... . tlesamfaat
Bacillus mkkmDpRaam mk....ealk elsavngddl llqmce. . . . ageqimreek
Acinetobacter . knfDpRakv mkqtcdevle alg.in.dpq lalameleri alndpyfver
Pseudomonas .knfDpRakv mkqtcdevlq elg.in.dpq lelamkleei arhdpyfver
Escherichia .knyDpRatv mretchevlk elg.tk.ddl levameleni alndpyfiek
Acetobacter .knfDpRaki mqqtchevlt elg.ikddpl ldlaveleki alsddyfvqr
Coxiella .knyDpRakv mqktcyevld avg.rhnepl fklaikleki aleddyfiek





fkgiaeklss kkpevhk..v yeiatkledf gika..fgsk
401 _ • _____________
Chicken heart aanpwPNvDa hsgvllqyyg 
Pig kidney aknpwPNvDa hsgvllqyyg 
Yeast (cytoplasm) tknpwPNvDa hsgvllqyyg 
Yeast (mitoch) tknpwPNvDs hsgvllqyyg 
Tetrahymena ianpyPNvDc hsgvllyslg 
Mycobacterium  ..rikPNID. fptgayylmd 
Bacillus ..glfPNlDy yaapvywklg 
Acinetobacter ..klyPNvDf ysgiilkaig 
Pseudomonas ..nlyPNvDf ysgiilkaig 
Escherichia ..klyPNvDf ysgiilkamg 
Acetobacter  ..klyPNvDf ysgiilkamg 
Coxiella ..klyPNvDf ysgltlnaig 
Rickettsia ..klyPNvDf ysgiiykamg 
Thermoplasma ..giyPNtDy fsgivymsig
Consensus  PN-D- — g------ g
< R3 > <------R4 ——>
Figure 6.1 Multiple sequence alignment of citrate synthases.
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451 * __ 478
Chicken heart lgfpleRPks mstd...gli al.....
Pig kidney lgfpleRPks mstd...gli klvdsk..
Yeast (cytoplasm) igasieRPks ystekykelv knieskl.
Yeast (mitoch) vgapieRPks fstekykelv kkieskn.
Tetrahymena fglpieRPgs adlkwfhdky re......
Mycobacterium ..naliRPls eysgqpqrsl v .......
Bacillus ..nrifRPrv lytgarnlrv ed......
Acinetobacter p.ykigRPrq lytgevqrdi kr.....
Pseudomonas p.ykigRPrq lytghtqrdf talkdrg.
Escherichia g.mkiaRPrq lyigyekrdf ksdikr..
Acetobacter pgqrisRPrq lyigapqrdy vplakr..
Coxiella pdhrlaRPrq lytgeterev isldkrqa
Rickettsia peqkisRPrq lytgyvhrey kciverk.
Thermopla sma q.qrliRPra vyvgpaerky vpiaerk.
Consensus ------ RP— ----------------- --------------
Figure 6.1 Multiple sequence alignment of citrate synthases.
Residues with Dayhoff matches of 1.2 or greater are in Upper Case 
(Schwartz & Dayhoff, 1979). The Dayhoff match between two amino acids 
reflects the probability of changing from one amino acid to any other, taking into 
account factors such as the required change in codon. It's value may vary from 
-1.2 to 1.5, where 1.5 indicates identity.
The consensus contains residues that occur in at least 12 of the 14 
sequences, regardless of their relative Dayhoff values.
Regions of secondary structure in the Pig enzyme are indicated by the 
horizontal bar above the alignment. Active site residues (▼) and substrate- 
binding residues (•) in the Pig enzyme are indicated.
Conserved regions considered for PCR primer design are marked R1 to
R4.
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Region 1: Region 2:
300 350
Chicken heart LaGplHG 1A Chicken heart GYGHaVl rkt.DpR
Pig kidney LaGplHG 1A Pig kidney GYGHaVl rkt.DpR
Yeast (cytoplasm) LaGplHG rA Yeast (cytoplasm) GYGHaVl rkt.DpR
Yeast (mitoch) LaGplHG rA Yeast (mitoch) GYGHaVl rkt.DpR
Tetrahymena LaGplHG •1A Tetrahymena GYGHaVl rdt.DpR
Mycohacterium LkGslHG gA Mycobacteri um GFGHrVy .kngDsR
Bacillus LkGhlHG gA Bacillus GFGHrVy mkkmDpR
Acinetobacter LwGpaHG gA Acinetobacter GFGHrVy .knfDpR
Pseudomonas LwGpaHG gA Pseudomonas GFGHrVy .knfDpR
Escherichia LwGpaHG gA Escherichia GFGHrVy .knyDpR
Acetobacter LwGpaHG gA Acetobacter GFGHrVy .knfDpR
Coxiella LwGpaHG gA Rickettsia GFGHrVy .ksyDpR
Consensus L-G— HG gA Thermopla sma GFGHrVy .ktyDpR
Consensus G-GH-V— ---- D-R
(Haloferax?) LwGpaHG gA (Haloferax?) GFGHrVy .k?yDpR
Region 3: Region 4:
401 431
Chicken heart wPNvDa hsg Chicken heart Tv lFgvsRalG
Pig kidney wPNvDa hsg Pig kidney Tv lFgvsRalG
Yeast (cytoplasm) wPNvDa hsg Yeast (cytoplasm) Tv lFgvsRafG
Yeast (mitoch) wPNvDs hsg Yeast (mitoch) Tv lFgvaRaiG
Tetrahymena yPNvDc hsg Tetrahymena Tv vFavsRalG
Mycobacterium kPNlD. fpt Mycobacterium Tp lFvmsRitG
Bacillus fPNlDy yaa Bacillus Tp iFfssRtvG
Acinetobacter yPNvDf ysg Acinetobacter Tv iFalaRtvG
Pseudomonas yPNvDf ysg Pseudomonas Tv iFalaRtvG
Escherichia yPNvDf ysg Escherichia Tv iFamaRtvG
Acetobacter yPNvDf ysg Acetobacter Tv lFavaRttG
Coxiella yPNvDf ysg Coxiella Tv iFalsRtvG
Rickettsia yPNvDf ysg Rickettsia Tv lFaiaRtvG
Th ermopl a sma yPNtDy f sg Th ermopl a sma Ta lFalsRvtG
Consensus -PN-D- ----- Consensus T- -F---R— G
(Haloferax?) yPNvDf ysg (Haloferax?) Tv iFa??Rt?G
Figure 6.2 Regions conserved in all known citrate synthase sequences
The possible corresponding sequences in Hf.volcanii are indicated. 
Question marks indicate positions where it was not possible to determine a 
likely residue for Hf.volcanii. Note that only completely conserved residues 
have been retained in the consensus for this analysis.
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Region 1:
L w G p a H G g A
5 1 -  CTC TGG GGC CCC GCC CAC GGC GGC GC
88% G+C
Region 2:
G F G H r V y k
5 ' -  GGC TTC GGC CAC CGC GTC TAC AA
65% G+C
Region 3:
y P N V D f y S q
51 - TAC CCC AAC GTC GAC TTC TAC TCG GG
A n t is e n s ATG GGG TTG CAG CTG AAG ATG AGC CC
e
52% G+C
Figure 6.3 Predicted DNA sequences corresponding to conserved 
regions in citrate synthase amino acid sequences
Region 3 alone was chosen for PCR primer design for the reason 
described in Section 6.2.1. The sequence of the anti-sense primer synthesised 
in shown above.
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Region 1 was eliminated as the predicted DNA sequence was greater 
than 85% G+C as such a high G+C content is likely to cause secondary 
structure formation, primer-dimer artefacts during PCR and possibly non­
specific binding of the primer. Region 4 was also eliminated because some 
positions in the predicted amino acid sequence were highly uncertain. Region 3 
was chosen over region 2 because a slightly longer primer could be made and 
a larger fragment of the gene could be amplified. A 26 base anti-sense 
consensus primer of the sequence given in Figure 6.3 was synthesised.
The Tp.acidophilum citrate synthase gene is 1152 bp in length, therefore 
the expected length of the PCR product is approximately 200 bp less; about 
960 bp.
6.2.2 PCR amplification with N-terminal and consensus primers
PCR reactions were carried out using 80 ng genomic DNA as template, 
0.4 pM primers and 50 pM dNTPs. Thirty cycles were performed, melting at 
94°C (1 minute), annealing at 55°C (1 minute 30 seconds) and extending at 
72°C (2 minutes). The magnesium concentration in the reactions was varied 
from 0.5 to 5 mM. Figure 6.4 shows examples of the PCR products, separated 
by electrophoresis on a 1% agarose gel.
A PCR fragment of 830 bp is apparent in the 1 to 5 mM Mg2+ lanes. This 
is approximately 130 bp shorter than expected (corresponding to a citrate 
synthase some 40 residues shorter than that of Tp.acidophilum), and was 
unlikely to be an amplified citrate synthase sequence, even though control 
reactions carried out in 1.5 mM Mg2+ using single primers confirmed that this 
band was not an artefact caused by one primer binding at multiple sites (Figure 
6.5).
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1 2 3 4 5 6 7 8
Figure 6.4 PCR amplification of genomic DNA using 29 base N-terminal 
and 26 base consesus primers, annealing at 55°C
Lane 1: X H/ndlll Lane 5: 2.0 mM Mg2+
Lane 2: 0.5 mM Mg2+ Lane 6: 3.0 mM Mg2+
Lane 3: 1.0 mM Mg2+ Lane 7: 5.0 mM Mg2+
Lane 4: 1.5 mM Mg2+ Lane 8: X Pst\
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Figure 6.5 PCR amplification of genomic DNA using 29 base N-terminal 
and 26 base consesus primers, annealing at 55°C
Lane 1: X Pst\
Lane 2: 1.5m M M g2+
Lane 3: 1.5 mM Mg2+ 29 base N-terminal primer control
Lane 4: 1.5 mM Mg2+ 26 base consensus primer control
The control reactions contained only the primer indicated.
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To confirm whether this product was correct, both ends were sequenced 
by the method described below.
A 10 pi aliquot of a 100 pi PCR reaction (1.5 mM Mg2+) was run on a 1% 
agarose gel, the 830 bp DNA band excised, purified using GeneClean and 
dissolved in 50 pi sterile Milli Q water. This product was re-amplified at the 
same Mg2+ concentration, annealing at 60 or 65°C, using 0.5 pi as template 
(Figure 6.6).
Re-amplification at 60°C produced the highest yield of the single band. 
Asymmetric PCR was carried out at this annealing temperature to produce 
single-stranded DNA for sequencing.
6.2.3 Asymmetric PCR amplification of 830 bp fragment
Asymmetric PCR was carried out as described in Section 2.3.15.2, using 
0.5 pi of the purified 830 bp band as template, at an annealing temperature of 
60°C and at an Mg2+ concentration of 1.5 mM. Thirty cycles were performed, 
melting at 94°C (1 minute), annealing at 55°C (1 minute 30 seconds) and 
extending at 72°C (2 minutes). One reaction contained 50 pmoles of the N- 
terminal primer and 1 pmole of the consensus primer (to produce an excess of 
the sense strand), while a second reaction contained 50 pmoles of the 
consensus primer and 1 pmole of the N-terminal primer (to produce an excess 
of the anti-sense strand).
The single-stranded DNA produced by both of these reactions was 
sequenced.
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Figure 6.6 PCR amplification of 830 bp band using 29 base N-terminal 
and 26 base consensus primers
Lane 1: X H/ndlll
Lane 2: Amplification from genomic DNA, 1.5 mM Mg2+, annealing 55°C
Lane 3: Re-amplification of 830 bp band, 1.5 mM Mg2+, annealing 60°C
Lane 4: Re-amplification of 830 bp band, 1.5 mM Mg2+, annealing 65°C
Lane 5: X Pst\
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6.2.4 Sequencing of asymmetric PCR products
Sequencing was carried out by the dideoxy method described in Section 
2.3.16, omitting the denaturation step. The sense strand was sequenced with 1 
pmole of the consensus primer, and the anti-sense strand with 1 pmole of the 
N-terminal primer. The Sequenase label mix was diluted 10 fold and 2 minute 
extension times were used in order to sequence close to the primers.
The sequence obtained by extension from the N-terminal primer was 
translated in three reading frames, while the sequence obtained by extension 
from the consensus primer was reversed and complemented (to read the sense 
strand) and then translated in three reading frames (Figure 6.7). No translated 
sequence showed any homology with any previously determined citrate 
synthase sequence, confirming this product to be an artefact. Both sequences 
were then translated in all reading frames and used to search the GenBank 
sequence database via the FASTA program from the GCG program package. 
No significant identity with any sequence in the database was observed.
6.3 PCR amplification of a 960 bp sequence from genomic DNA 
using determined N-terminal and C-termlnal amino acid sequences 
for primer design
Once the internal citrate synthase protein sequence described in Chapter 
Five became available, improved PCR reactions were undertaken, using these 
data.
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Sequence of 830 bp PCR product obtained with N-terminal primer:
S T L * E V S R I S R P R F R R A P S G E  
R R C K R C R E S L D R D F A A L H Q A N  
D A V R G V E N L S T A I S P R S I R R M  
TCGACGCTGTAAGAGGTGTCGAGAATCTCTCGACCGCGATTTCGCCGCGCTCCATCAGGCGAA  
10 20  30  40  50  60
AGCTGCGACATTCTCCACAGCTCTTAGAGAGCTGGCGCTAAAGCGGCGCGAGGTAGTCCGCTT  
R R Q L L H R S D R S R S K A A S W * A F  
S A T L P T S F R E V A I E G R E M L R I  
V S Y S T D L I E R G R N R R A G D P S H
Sequence of 830 bp PCR product obtained with consensus primer:
A E Q P R I P A R T A * R Q K L F Y P C  
L N S P A F R R E P L D D R N Y  F T R A  
* T A P H S G A N R L T T E T I L P V P  
GCTGAACAGCCCCGCATTCCGGCGCGAACCGCTTGACGACAGAAACTATTTTACCCGTGC  
10  20  30  40  50  60
CGACTTGTCGGGGCGTAAGGCCGCGCTTGGCGAACTGCTGTCTTTGATAAAATGGGCACG  
S F L G A N R R S G S S S L F * K V R A  
Q V A G C E P A F R K V V S V I K G T G  
S C G R M G A R V A Q R C  F S N *  G H R
R L D V R S Y Q T N H G D Y  R H L S D E  
D * M * G R T K Q I M E I T D I S A T K  
I  R C E V V P N K S W R L Q T S Q R R K  
CGATTAGATGTGAGGTCGTACCAAACAAATCATGGAGATTACAGACATCTCAGCGACGAA  
70  80  90  100  110  120
G C TAA TCTAC AC TCC AG CA TG G TTTG TTTA G TA CC TCTAA TG TCTG TA G A G TC G C TG CTT  
S *  I H P R V L C I M S I V S M E A V F  
I L H S T T G F L D H L N C V D * R R F  
N S T L D Y W V F * P S * L C R L S S F
N Q Q R V V G R V H R V P A R H  
I S N E S W G E F I E F P L V T  
S A T S R G A S S S S S R S S P  
AATCAGCAACGAGTCGTGGGGCGAGTTCATCGAGTTCCCGCTCGTCACCA  
130  140  150  160
TTAGTCGTTGCTCAGCACCCCGCTCAAGTAGCTCAAGGGCGAGCAGTGGT  
I L L S D H P S N M S N G S T V  
D A V L R P A L E D L E R E D G  
* C R T T P R T * R T G A R * W
Figure 6.7 Sequences of each end of the 830 bp PCR fragment
Single-stranded DNA was produced by asymmetric PCR and sequenced 
with the same primers as were used for the amplification.
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6.3.1 Primer design
The sense primer used was the non-degenerate 29 base oligonucleotide 
made to the citrate synthase N-terminal amino acid sequence (described in 
Figure 4.16).
The anti-sense primer was designed from the amino acid sequence of 
the cyanogen bromide cleavage fragment described in Section 5.5.2, with 
reference to the codon-usage data in Figure 4.1. Its sequence is shown in 
Figure 6.8.
The expected length of the PCR product was approximately 980 bp.
6.3.2 PCR amplification with N-terminal and C-terminal primers
PCR reactions were carried out using 80 ng genomic DNA as template, 
0.4 pM primers and 50 pM dNTPs. Thirty cycles were performed, melting at 
94°C Sequenceof 830 bp PCR product obtained with N-terminal primer:(1 
minute), annealing at 55°C (1 minute 30 seconds) and extending at 72°C (2 
minutes). The magnesium concentration in the reactions was varied from 0.5 to 
5 mM. Figure 6.9a shows examples of the PCR products, separated by 
electrophoresis on a 1% agarose gel. Control reactions performed at the same 
time indicate that at 55°C (and 20 mM Mg 2+) the N-terminal primer binds at 
more than one position, causing products to be formed when it is the sole 
primer present. These products were larger than the desired fragments and 
while undesirable, did not interfere with their detection at this point (Figure 
6.9b). At an annealing temperature of 55°C and a Mg2+ concentration of 5 mM, 
a product of 960 bp is formed. This product was of the expected size, although 
the amplification was not very specific.




I P I D L Y T P I F A V S R A G
A T A CCA A T A GAC C TA TAC AAA CCA A T A TTC GCA GTA TC A CGA GCA GGA
C G C T G T G G C T G G G G G G
T C T C C C T C C C C C C
T T T T T T T T T T
T T A AGC
G T
S e n s e  A TC  CCG A TC  GAC CTC TAC ACG CCC A TC  TTC  GC
O l i g o  TAG GGC TAG CTG GAG A TG  TGC GGG TAG AAG CG - 5 '
G
Figure 6.8 Sequence of anti-sense PCR primer designed from amino acid sequence
The amino acid sequence and potential codons are shown. The primer sequence is in bold and includes the 
degeneracy shown.
Figure 6.9a,b PCR amplification 960 bp band using N-terminal and C- 
terminal primers
a. Lane 1:XPst\  b. Lane ^:XPst\
Lane 2: 0.5 mM Mg2+ Lane 2: 2 mM Mg2+, N-terminal primer control
Lane 3: 1.0 mM Mg2+ Lane 3: 2 mM Mg2+, C-terminal primer control
Lane 4: 1.5 mM Mg2+
Lane 5: 2.0 mM Mg2+
Lane 6: 3.0 mM Mg2+
Lane 7: 5.0 mM Mg2+
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As many PCR products were formed, the annealing temperature was 
raised to 60°C to reduce the level of non-specific primer binding. The result in 
Figure 6.10 demonstrates an improvement in the N-terminal primer control as 
products are no longer formed by this primer alone. The only product whose 
yield was improved by the higher annealing temperature is an 860 bp fragment 
evident in the 0.5-1.5 mM Mg2+ lanes. This is approximately 120 bp 
(corresponding to 40 residues) shorter than would be expected and unlikely to 
contain the desired sequence. This product was purified and re-amplified by 
asymmetric PCR as described in 6.2.3, in order to confirm this assertion; 
however, under these conditions the yield of single-stranded DNA was too low 
to permit sequencing.
The 960 bp product amplified at an annealing temperature of 55°C and 5 
mM Mg2+ was investigated further. A 10 pi aliquot of a 100 pi PCR reaction (5 
mM Mg2+) was run on a 1% agarose gel, the 960 bp DNA band excised, 
purified using GeneClean and dissolved in 50 pi sterile Milli Q water. This 
product was re-amplified over a range of Mg2+ concentrations, annealing at 
60°C, using 0.5 pi as template (Figure 6.11).
Asymmetric PCR was also carried out under the conditions described in 
6.2.3 to confirm the presence of citrate synthase sequence. The yield of single­
stranded DNA was too low to allow direct sequencing by this method.
6.4 Discussion
The current state of this project is that a 960 bp DNA fragment has been 
amplified from genomic DNA. Due to time constraints I was unable to confirm 
that this product contains a citrate synthase gene sequence. This is currently 
being undertaken by our research group by a route involving blunt-ended
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1 2 3 4 5 6 7 8
Figure 6.10 PCR amplification 960 bp band using N-terminal and C 
terminal primers, annealing at 60°C
Lane 1: 1.0 mM Mg2+
Lane 2: 1.5m MMg2+
Lane 3: 2.0 mM Mg2+
Lane 4: 3.0 mM Mg2+
Lane 5: 5.0 mM Mg2+
Lane 6: 2.0 mM Mg2+, N-terminal primer control 
Lane 7: 2.0 mM Mg2+, C-terminal primer control 
Lane 8: X Pst\
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Figure 6.11 PCR amplification 960 bp band using N-terminal and C 
terminal primers, annealing at 60°C
Lane 1: X Pst\
Lane 2: 0.5 mM Mg2+ 
Lane 3: 1.0 mM Mg2+ 
Lane 4: 1.5 mM Mg2+ 
Lane 5: 2.0 mM Mg2+ 
Lane 6: 3.0 mM Mg2+ 
Lane 7: 5.0 mM Mg2+
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cloning of the re-amplified product into a pUC vector. This will allow normal 
double-stranded DNA sequencing methods to be used. The 860 bp PCR 
product is shorter than one would expect for a section of a citrate synthase 
gene amplified between the N-terminal and C-terminal primers. The expected 
length of a product is some 120 bp greater, corresponding to about 40 amino 
acids in the protein. This difference is too small to dismiss this product as an 
artefact and should therefore be sequenced and retained or discarded on the 
basis of sequence data.
Once a gene sequence is obtained, perfectly matched oligonucleotide 
probes will be synthesised and used to probe restriction digested genomic DNA 
on Southern blots. By making probes close to both the N-terminal and C- 
terminal ends of the gene, a restriction fragment that has a high probability of 
containing the entire gene and flanking regions can be identified. Such a 
fragment would be at least 2 kb in length and hybridise to both probes.
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Chapter
Analysis of 939 bp open reading frame within the 2.9 kb Psfl 
I EcoRI clone
7.1 Introduction
Chapter Four describes the screening of genomic DNA restriction 
fragments with a 44 base oligonucleotide probe designed from the N- 
terminal sequence of Hf.volcanii citrate synthase. A 2.9 kb Psfl / EcoRI 
fragment was isolated and cloned using this probe. Sequence analysis of 
this clone revealed that it did not contain the citrate synthase gene, although 
a FASTA search (GCG program package) of the Swissprot protein database 
with the translated DNA sequence revealed a putative open reading frame of 
an unrelated gene. This chapter describes the sequencing and analysis of 
the 939 bp open reading frame.
7.2 Sequence analysis
Sequencing was carried out as described in Chapter Four using the 
protocols given in Section 2.3.16. As the full characterisation and expression 
of this gene was outside the scope of this project, the sequence was 
determined in a single direction only. Figure 7.1 shows the position of the 
gene within the 2.9 kb insert and indicates the regions sequenced.
The gene sequence and corresponding amino acid sequence are 
given in Figure 7.2.
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Figure 7.1 Position of the open reading frame within the 2.9 kb Psfl I
EcoRI clone
The positions of the start codon (M) and stop codon (*) are indicated. 
The open reading frame is on the reverse strand.
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CGGATTCCGTACGACTGGAACGCGGAAATCCACGGCTAAACAGCAACCTGCCAGCAGGGC
GCCTAAGGCATGCTGACCTTGCGCCTTTAGGTGCCGATTTGTCGTTGGACGGTCGTCCCG
B o x  B? B o x  A ?
ACAAACTTA T T T A GTACCGTGTCAGGTATCGTCTCATATCGATGAAAGGCGTACTTCTCT
T GTTT GAAT AAAT CAT GGCACAGT CCATAGCAGAGT A T  AGCTACTTTCCGCATGAAGAGA
M K G V L L S -
CAGGAGGCACGGGCTCCCGTCTCCGACCCATTACCCACACCGGGCCGAAGCAACTCGTTC
1 2 1 -------------------------------------------+ -------------------------------------+ ---------------------------------------- + --------------------------------------------+ ---------------------------------------- + -----------------------------------------+  180
GTCCTCCGTGCCCGAGGGCAGAGGCTGGGTAATGGGTGTGGCCCGGCTTCGTTGAGCAAG
G G T G S R L R P  I  T H T  G P  K Q L V P -
CGGTCGCGAATAAACCCGTCCTCGAATACGCGGTCGAGGACCTCAAAGAAGCGGGAATCA
1 8 1 -------------------------------------------+ -------------------------------------+ ---------------------------------------- + --------------------------------------------+ ---------------------------------------- + -----------------------------------------+  240
GCCAGCGCTTATTTGGGCAGGAGCTTATGCGCCAGCTCCTGGAGTTTCTTCGCCCTTAGT
V A N K P V L E Y A V E D L K E A G I  T  -
CCGAAATCGGCGTCATTCTCGGCCACAAGGGCCGCGAGGAGATTCAGAACCTCCTCGGCG
241 --------- +--------- +--------- +---------- +--------- +--------- + 300
GGCTTTAGCCGCAGTAAGAGCCGGTGTTCCCGGCGCTCCTCTAAGTCTTGGAGGAGCCGC
E I G V I L G H K G R E E I Q N L L G D -
ATGGTTCGGACTACGGCGTCGAGATTACCTACATCGTCCAAGGGAACCCCCTCGGCCTCG
301 ---------------------------------------+ ---------------------------------------- + ---------------------------------------- + --------------------------------------------+ ---------------------------------------- + -----------------------------------------+  360
TACCAAGCCTGATGCCGCAGCTCTAATGGATGTAGCAGGTTCCCTTGGGGGAGCCGGAGC
G S D Y G V E I T Y I V Q G N P L G L A -
CCCACGCGGCGGGCTGTGCGAAGGACTTCGTCGGCGACGACGACTTCGTGATGTACCTCG
361 ------------------------------------ + ---------------------------------------- + ---------------------------------------- + --------------------------------------------+ ---------------------------------------- + -----------------------------------------+  420
GGGTGCGCCGCCCGACACGCTTCCTGAAGCAGCCGCTGCTGCTGAAGCACTACATGGAGC
H A A G C A K D  F V G D  D D F V M Y L G -
GAGATAACATCCTCAAAGAGGGCGTCGTCGACCTCGTCGAAAGCTTCGAGTCGGGCGACT
421 --------------------------------------- + ---------------------------------------- + ---------------------------------------- + --------------------------------------------+ ---------------------------------------- + ----------------------------------------- +  480
CTCTATTGTAGGAGTTTCTCCCGCAGCAGCTGGAGCAGCTTTCGAAGCTCAGCCCGCTGA
D N I L K E G V V D L V E S  F E S G D F -
TCGGTGCGGGCATCGCCCTACAGGAAGTCGAGAACCCACAGGAGTTCGGGATTGCGGACG
481 ---------------------------------------+ ----------------------------------------+ ---------------------------------------- + ------------------------------------------- + ---------------------------------------- + -----------------------------------------+  540
AGCCACGCCCGTAGCGGGATGTCCTTCAGCTCTTGGGTGTCGTCAAGCCCTAACGCCTGC
G A G I A L Q E V E N P Q Q F G I A D V -
Figure 7.2 Sequence of open reading frame and corresponding amino 
acid sequence
The start codon is shown in bold. Putative promotor regions (Box A 
and B) are underlined.
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TCGACGACCAGGGTAACGTCACCCAACTCATCGAGAAGCCGGACGAGCCGCCGACGAATC
5 4 1 -----------   1-----------------------------------------------1--------------------------------------------1------------------------------------------1----------------------------------------1---------------------------------------------------1-  600
A G CTG CTG G TC CCATTG CAG TG G G TTG AG TAG CTCTTCG G CCTG CTC GG CG G CTG CTTAG
D D Q G N V T Q L I  E K P D E P  P T N L -
TCGCACTCATCGGGATGTACGTCTTCTCGCCCGCGGTCTTCGACGCCATCGAGCAACTCG
601  1-----------------------------------------------1--------------------------------------------1------------------------------------------1----------------------------------------1---------------------------------------------------1-  660
AGCGTGAGTAGCCCTACATGCAGAAGAGCGGGCGCCAGAAGCTGCGGTAGCTCGTTGAGC
A  L  I  G M Y V F S  P A V F D A I  E Q L E -
AACCCTCGTGGCGCGGCGAACTCGAAATCACGGACGCGATTCAGTCACTCCTCGAAGACG
TTGGGAGCACCGCGCCGCTTGAGCTTTAGTGCCTGCGCTAAGTCAGTGAGGAGCTTCTGC
P S W R G E L E I  T D A I  Q S  L L E D G -
GCTACGCCATCGACTCGCACGTCGTCGAAGGCTGGTGGAAAGACACCGGCAAGCCCGAAG
CGATGCGGTAGCTGAGCGTGCAGCAGCTTCCGACCACCTTTCTGTGGCCGTTCGGGCTTC
Y A  I  D S H V V E G W W K D T G K P E D -
ACATCCTCGAGGCGAACCAACTCGTCCTCGAAGACAAGTCGCTCAAAAAGCGGGGCACCG
781 ----------------------------------------+ ------------------------------------------+ ---------------------------------------- + ---------------------------------------- + --------------------------------------+ ---------------------------------------------+  840
TGTAGGAGCTCCGCTTGGTTGAGCAGGAGCTTCTGTTCAGCGAGTTTTTCGCCCCGTGGC
I  L E A N Q L V L E D K S  L K K R G T V -
TCAGCGACGATGAGACCGTCGATGGACGTATCGAACTCGCGGAGTCAGCGACCATCGAAG
841 ----------------------------------------+ --------------------------------------------+ ---------------------------------------- + -------------------------------------- + --------------------------------------+ --------------------------------------------- +  900
AGTCGCTGCTACTCTGGCAGCTACCTGCATAGCTTGAGCGCCTCAGTCGCTGGTAGCTTC
S D D E T V D G R I  E L A E  S A T  I  E D -
ACGGCGCAGTCGTCCGTGGCCCGGTCTCTATCGCGGATGGCGCGGTCATCAAATCGGGCA
901 ----------------------------------------+ --------------------------------------------+ ---------------------------------------- + --------------------------------------+ --------------------------------------+  +  960
TGCCGCGTCAGCAGGCACCGGGCCAGAGATAGCGCCTACCGCGCCAGTAGTTTAGCCCGT
G A V V R G P V S  I  A  D G A  V  I  K S G T -
CCTACGTCGGCCCGTACACGTTTCGGTCCGAACTCGACACTCGAAGGCGTCCACATCGAG
961  + -------------------------------------------+ ---------------------------------------- + -------------------------------------- + --------------------------------------+  +  1020
GGATGCAGCCGGGCATGTGCAAAGCCAGGCTTGAGCTGTGAGCTTCCGCAGGTGTAGCTC
Y V G P Y T F R S E L D T R R R P H R E -
AACTCGGTCGTCATCGGTGAGTCGAGCATCAACACCTCCGGCCGCATCGTTGACAGCCTC
1021  + -------------------------------------------+ ---------------------------------------- + --------------------------------------+ --------------------------------------+ --------------------------------------------- +  1080
TTGAGCCAGCAGTAGCCACTCAGCTCGTAGTTGTGGAGGCCGGCGTAGCAACTGTCGGAG
L  G R H R *
Figure 7.2 Continued
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CTCGGGAAGGGTCGCGAACATCGGCAGTGCGGACGACTTCCTCCCGGAGGGTCGTCGCCT
1 0 8 1 ----------------------------------------+ ----------------------------------------+ ---------------------------------------- + ---------------------------------------- + -----------------------------------------+ -----------------------------------------+  1140
GAGCCCTTCCCAGCGCTTGTAGCCGTCACGCCTGCTGAAGGAGGGCCTCCCAGCAGCGGA
CGTCGTTGGCGAGGGCTCCCAACTGAAACTCTAACCATGCACATCATCACCCACGCCTGT
1 1 4 1 ------------------------------------------- + --------------------------------------+ ---------------------------------------- + ---------------------------------------- + ---------------------------------------- +  +  1200
GCAGCAACCGCTCCCGAGGGTTGACTTTGAGATTGGTACGTGTAGTAGTGGGTGCGGACA
ACGCAGTGCGGAACCGTCGTCTCCGCGAACGAACTCGAATCGAACCGCGTGATGAAGTGC
1201  + -----------------------------------------+ ---------------------------------------- + ---------------------------------------- + ---------------------------------------- + ----------------------------------------+  1260
TGCGTCACGCCTTGGCAGCAGAGGCGCTTGCTTGAGCTTAGCTTGGCGCACTACTTCACG
CCCGGA
1261   1266
GGGCCT
Figure 7.2 Continued
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7.3 Database search results
The Genbank and EMBL databases were searched with the complete 
translated sequence of the open reading frame. The results of the search are 
given in Table 7.1 below.
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M87049 Daniels et al. 
(1992)
Genomic region 325 
to 333
Bacillus subtilis 40.6% in 
244 aa 
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L14842 Rajakumar et al. 
(1994)
rfbC or rfbD (dTDP-6- 
deoxy-D-glucose-3,5 





































L23941 Koeplin et al. 
(1993)
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1 50
H f .v o lc a n i i  ORF .......................................................................................................................... m K g v lL s G G t
S.gr iseus  .......................................................................................................................... m K a lv L a G G t
E .c o l i  .......................................................................................................................... m K g im LaG G s
N .m e n in g it id is  v a k c i e r q l s  f g t f r y w k i v  f r r h p d a m p s  e n p s q r k k e k  m K g iiL a G G s
B. s u b t i l i s  .......................................................................................................................... v K g v iL a G G n
C o n s e n s u s  ----------------------- -------------------------- -------------------------- -------------------------- - K  L -G G -
H f .v o lc a n i i  ORF 
S.gr iseus  
E .c o l i  
N. m e n in g i t id is  
B . s u b t i l i s  
C o n s e n s u s
51
G s R L r P iT h t  
G t R L r P iT h t  
G tR L h P iT r g  
G tR L y P iT r g  
G s R L m P lT k a  
G - R L - P - T —
g p K q L v P V a n  
s a K q L v P V a n  
v s K q L lP I y d  
v s K q L lP V y d  
v n K h L lP V g p  
— K - L - P V —
k P v le Y a v e d  
k P v l f Y g le a  
k P m iy Y p ls v  
k P m iy Y p ls v  
y P m iy W s im k  
- P  Y ---------
I k e A G I t E I g  
i r a A G I iD V g  
l m l A G I r E I l  
l m l A G I r D I l  
l q e A G I k D I l  
 A G I - D I -
100
v l l g h k g r e e  
i V v g d t a . d e  
i l t t p e d k g y  
v l t a p e d n a s  
l l s q k e h m p q
H f .v o lc a n i i  ORF 
S.gr iseus  
E .c o l i  
N .m e n in g it id is  
B . s u b t i l i s  
C o n s e n s u s
101
i q n l l G d g s d  
iv a a v G d g s r  
f q r l l G d v g e  
f k r l l G d g s d  
f y k l lG n g e e
Y G v e i t Y iv Q  
F G lk v s Y ip Q  
F G iq le Y a e Q  
L G is is Y a v Q  
L G v t i t Y q v Q  
- G --------- Y— Q
g n p lG la h a a
s k p lG la h c v
p s p d G la q a f
p s p d G la q a f
p a a s G is d g l
g c a k d F v g d D  
l i s r d F l g e D  
i i g e t F l n g E  
i i g e e F ig n D  
s y a k r F t k k E  
 F  D
150
d fv M y L G D N i 
d f iM y L G D N f  
p s c L v L G D N i 
n v c L v L G D N i 
s f i L l L G D N i  
 L -L G D N -
H f .v o lc a n i i  ORF 
S .gr iseus  
E .c o l i  
N. m e n in g i t id is  
B . s u b t i l i s  
C o n s e n s u s
151
l k e . g v . v l v  
w g . w e d s v  
f f g q g f s p k l  
f y g q s f t q t l  
f . e d s l k p y t
e s f e s g d f g a
r e f r a a r p d a
r h v a a r t e g p
k q a a r q t h g a
e r f e q q g k g a
g ia lq e V e n P  
h lm l t r V p e P  
. v fg y q V m d P  
t v fa y q V k n P  
k v l l k e V d d P  
--------------V — P
q q F G ia D v d D  
r s F G v a E ls D  
e r F G x v E fd D  
e r F G w E f n E  
e r F G ia E id E  
— FG— E— D
200
q g . n v t q l i E  
s g . q v l g l e E  
. n f r a i s l e E  
. n f r a v s i e E  
k n k r i r s i i E
H f .v o lc a n i i  ORF 
S .gr iseus  
E .c o l i  
N. m e n in g i t id is  
B. s u b t i l i s  
C o n s e n s u s
201
K P d e P p tn la  
K P a h P k s d la  
K P k q P k s n w a  
K P q rP k s d w a  
K P e q P p tn lc  
K P— P-----------
l iG m Y v F s p a  
lv G v Y lF s p a  
v t G lY f Y d s k  
v t G l Y f Y d n r  
v tG iY m Y d a e  
— G - Y - Y ------
v f d a i e q l e P  
i h e a v a a i t P  
w e y a k q v k P  
a v e f a k q i k P  
v f s y i e q i s P
S w R G E LE IT d
S w R G E L E IT d
S e R G E L E IT s
S a R G E L E IT d
S k R G E L E IT d
S -R G E L E IT -
250
a i q s l l E d g y
a v q w l iD a g r
in q m y lE a g n
I n r m y lE d g s
v n n ly iE n s q
H f .v o lc a n i i  ORF 
S . griseus  
E .c o l i  
N. meningi t i d i s  
B . s u b t i l i s  
C o n s e n s u s
251
a id s h w e G W  
d v r s t v i s G Y  
l t v e l l g r G F  
l s v q i l g r G F  
l t y d v l s . GW
. W k D tG k p e d  
. W k D tG n v td  
a W lD tG th d s  
a W lD tG th e s  
. W v D a G th e s  
-W -D -G ---------
i l e a n q L V l e  
m le v n r L V le  
l i e a s t F V . q  
lh e a a s F V . q  
l y l a s q L V h q  
-------------- LV —
300
d k s l k k r g t v  s d d e t v d g r i  
t t e p r c d g l v  d e r s d l i g r v  
t v e k r q g f k i  a c l e e ia w r n  
t v q n i q d l q i  a c l e e ia w r n  
a l r k g q d e k *  ..........................
Figure 7.3 Alignment of the Hf.volcanii open reading frame (ORF) with 
the four sequences of highest identity from the database search
The uppercase letters denote conserved or conservatively replaced 
residues. The alignment was produced using PILEUP. Refer to Table 7.1 for 
the functions of these genes.
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301 350
Hf. v o lc a n i i  ORF e l a e s a t i e d  g a w r g p v s i  a d g a v i k s g t  y v g p y t f r s e  ..........................
S.g r iseus  l v e e g a e v r n  s r v m g p t v i g  a g t r v t n s . .  y v g p f t s l a e  d c v v e d s e v e
E .c o l i  g w ld d e g v k r  a a s s l a k t g y  g q y l l e l l r a  r p r q y * ..........................................
N .m e n in g it id is  g w le k k d v e t  r a k p l e k t a y  g q y l l h l i g k  * .........................................................
B . s u b t i l i s  .........................................................................................................................................................
C o n s e n s u s  -----------------------  • -------------------------- -------------------------- --------------------------
351 400
Hf. v o lc a n i i  ORF   l d t r r r p h r e  l g r h r * .........................................................................
S. gr iseus  f s i v l r g a s i  s g v r r i e a s l  i g r h v q v t s a  p e v p h a n r l v  l g d h s r a q i s
E .c o l i  .........................................................................................................................................................
N. m e n in g i t id is  .........................................................................................................................................................
B. s u b t i l i s  .........................................................................................................................................................
C o n s e n s u s  ----------------------- -------------------------- -------------------------- -------------------------- --------------------------
H f .v o lc a n i i  ORF 
S. g r iseus  
E .c o l i  
N. m e n in g i t id is  
B . s u b t i l i s  
C o n s e n s u s
401
Figure 7.3 Continued
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13%. This is consistent with the theory that halophilic proteins contain acidic 
residues that stabilise them under high salt conditions, as described in 
Section 1.6.
Of the sequences given in Table 7.1, two are of unknown function 
(B.subtilis genomic region 325-333 and E.coli genomic 84.5-86.5), one is a 
UDP-glucose-4-epimerase, one a dTDP-glucose 4,6-dehydratase and one 
either a dTDP-6-deoxy-D-glucose-3,5 epimerase or a dTDP-6-deoxy-L- 
mannose dehydrogenase. The remainder are putative (S.griseus, 
Y.enetrocolitica and X.campestris) or confirmed (S.enterica) glucose-1- 
phosphate thymidylyltransferases.
The S.griseus glucose-1-phosphate thymidylyltransferase is proposed 
to be involved early in the biosynthetic pathway of streptomycin (Distler et al, 
1987, Distler etal., 1992). With the exception of the S.flexneri dTDP-glucose 
4,6-dehydratase, roles have been proposed for all of the other activities in 
the biosynthesis of lipopolysaccharides. In Y.enterocolitica and the 
Salmonella species the lipopolysaccharide in question is a surface antigen, 
while the Acaulinodans gene is part of a lipopolysaccharide operon involved 
in nodule formation.
The Hf. volcanii open reading frame may code for an enzyme that has 
glucose-1-phosphate thymidylyl or urdiylyl transferase activity, activating a 
carbohydrate moiety by nucleotidylation prior to its polymerisation into a 
polysaccharide. Alternatively the gene product may accept a nucleotidylated 
sugar as a substrate and act as an epimerase or dehydratase.
If the Hf. volcanii open reading frame codes for a sugar-activating 
enzyme, it is likely to have a fundamental role in polysaccharide 
biosynthesis. It has been proposed that nucleotide-activated sugars (UDP- 
glucose, UDP-mannose and UDP-galactose) are added to an unidentified 
glycolipid precursor during the biosynthesis of glycolipids in Hf. volcanii
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(Kates, 1994). The biosynthesis of the Hf. volcanii S-layer glycoprotein also 
utilises nucleotide-activated sugars (Kandler & Konig, 1994).
Further study of this open reading frame requires confirmation of its 
sequence by sequencing both strands, followed by characterisation of the 
activity of the protein which it encodes. This could be approached by PCR 
amplification of the gene using primers containing restriction sites which 
would allow it to be cloned into an E.coli expression vector. The gene could 
then be expressed in E.coli under the control of a powerful, inducible 
promotor (such as tac) and the enzyme activated by addition of salt. If the 
expressed protein is found to be insoluble, solubility may be improved by 
growing the transformed E.coli at 30-32°C. Activation of the enzyme may not 
be achieved by the simple addition of KCI to a cell extract. It may be 
necessary to partially unfold the expressed enzyme and allow it to refold into 
an active conformation by addition of guanidine hydrochloride followed by 
dialysis against a high KCI buffer, or by heating the inactive enzyme in a 
high KCI buffer and allowing it to cool.
The development of an assay to determine the activity of the 
expressed enzyme should be undertaken with care as the enzyme may be 
inactive due to incorrect folding. Adding 2 M KCI to a cell extract (produced 
by sonication) acts as an initial purification as many E.coli proteins are 
precipitated under these conditions. A subsequent dialysis step would then 
remove nucleotide triphosphates and nucleotidylated sugars which could 
interfere with assays.
Simple spectrophotometric assays for glucose-1-phopshate 
thymidylyltransferase rely on addition of pyrophosphate and dTDP-glucose 
as substrates, catalysing the formation of glucose-1-phosphate, which is in 
turn converted to glucose-6-phosphate by phosphoglucomutase (in the 
presence of its activator, glucose-1,6-bisphosphate) which is coupled to 
glucose-6-phosphate dehydrogenase and the reduction of NAD is followed
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spectrophotometrically (Komfeld & Glaser, 1961). This type of coupled 
assay is unsuitable for use with a halophilic enzyme. An alternative system 
has been developed using HPLC analysis of aliquots taken from a reaction 
between glucose-1-phosphate and dTTP, forming dTDP-glucose and 
pyrophosphate (Lindquist et al., 1993). This method is also unsuitable as it 
relies on a non-halophilic pyrophosphatase to affect the equilibrium of the 
reaction.
A possible method for a halophilic enzyme would be to incubate the 
cell extract (prepared as described above) with a radiolabelled sugar- 
phosphate and dTDP or UDP, stop the reaction and purify the nucleotide 
diphosphate sugar by adsorption to charcoal, eluting with a solution of 
ammonia in ethanol/water (Okazaki et al., 1961). The incorporation of 
radiolabel could be measured for a variety of different combinations of 
sugar-phosphates and dTDP or UDP, to determine the preferred substrate.
An epimerase activity may be detected by incubation of the enzyme 
with a potential substrate, followed by purificaction of the substrate-product 
mixture by adsorption as above. Analysis by HPLC of aliquots taken at 
various time points during the incubation would reveal any reaction that had 
taken place.
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Chapter g
Conclusions and suggested further work
The strategy of purifying a protein, determining its N-terminal 
amino acid sequence and using a corresponding synthetic 
oligonucleotide probe to screen for its gene is well established. In our 
laboratory this route has been successfully taken in cloning the citrate 
synthase gene (Sutherland et al., 1990) and the glucose 
dehydrogenase gene (Bright et al., 1991) from the Archaeon 
Thermoplasma acldophilum. In each case both long, unique probes and 
short, degenerate probes were used, the citrate synthase gene being 
identified using the former type of probe and the glucose 
dehydrogenase with the latter. Both of these approaches to the design 
of probes were therefore considered appropriate for this project.
Short, degenerate probes designed to Hf. volcanii citrate synthase 
amino acid sequence were found to lack the required specificity when 
hybridising to genomic DNA. Longer, unique probes appear to offer a 
greater chance of success in following up this work. The marked 
preference for certain codons in the Hf. volcanii genome makes their 
deign easier.
Trieselmann and Charlebois (1992) have shown by cDNA 
hybridisation to genomic DNA that regions of the relatively A-T rich Fll 
DNA of the Hf.volcanii genome are transcriptionally active. There may 
be protein coding genes within these areas whose codon preference 
differs from that described in Figure 4.1. Probes designed using codon 
preference data from G-C rich regions would be less likely to hybridise 
to such genes. This may be relevant to our search for the citrate
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synthase gene. A comprehensive survey of codon preference in 
halophilic Archaea has recently been carried out (Soppa, 1993). The 
majority of the genes surveyed possessed the same G-C biased codon 
preference, including those used to compile Figure 4.1. To date, only 
the gas vacuole genes of the Halobacteria are known to have a 
significantly different (relatively A-T) rich codon preference. On balance 
it still appears valid to have designed the probes to the G-C rich codon 
preference.
The next step to be taken with this project should be the cloning 
and sequencing of the 960 bp PCR product described in Section 6.3.2. 
A pair of 20-30 base oligonucleotides designed to match the ends of a 
correctly amplified product could be used to probe restriction-digested 
genomic DNA. A fragment of 2 to 3 kb to which both probes bound 
would be highly likely to contain the entire gene. Should both of the 
PCR products described in Section 6.3.2 prove to be artefacts, the 29 
base PCR primer designed from the amino acid sequence at the C- 
terminal end of the protein has the potential to be used as a probe.
At the outset of this project it was our intention eventually to 
express the Hf. volcanii citrate synthase in E.coli, prepare crude cell 
extracts by sonication and use the addition of salt to both activate the 
Hf. volcanii enzyme and concommitantly to precipitate many of the 
contaminating E.coli proteins. Cendrin etal. (1993) have since 
demonstrated that it is possible to achieve high level expression of a 
halophilic malate dehydrogenase in a soluble form in E.coli. The 
enzyme was fully activated by the addition of NaCI to a concentration of 
3 M. The Hf. volcanii dihydrofolate reductase has also been expressed 
in E.coli, but in an insoluble form that was activated by denaturing in 
guanidine hydrochloride, followed by dilution into high salt solutions.
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If the Hf. volcanii citrate synthase is found to express as an 
incorrectly folded polypeptide that resists folding upon the addition of 
either high salt or guanidine, the option of expression in Hf. volcanii is 
still open. Hf.voicanii is a fast growing organism that reaches a high 
density in culture and an effective means of enzyme purification is 
available in the Red A affinity column. Expression in Hf.voicanii has the 
advantage that the polypeptide is likely to fold correctly, but has the 
drawback that expression would be from its own promotor rather than 
the highly efficient, inducible promotors (such as tac) available in E.coli 
expression systems.
In order to study the basis of halophilicity by site-directed 
mutagenesis one needs detailed knowledge of the structure of the 
enzyme under investigation. A crystal structure has yet to be 
determined for a halophilic enzyme, so until such time mutagenesis 
studies must rely upon predicted structural models, such as that for the 
Hf. volcanii dihydrofolate reductase (Bohm & Jaenicke, 1994). The 
crystal structure of the Tp.acidophilum citrate synthase has now been 
determined (Russell et al., 1993) and may be a useful point from which 
to start homology modelling the Hf.voicanii enzyme once its sequence 
is known, while crystallisation trials are started. As citrate synthases 
are composed almost entirely of a-helices it will be interesting to see if 
any in the Hf.voicanii enzyme have the "halophilic helix motif' (negative 
charge clusters at the N-terminal end of a helix) observed in the 
dihydrofolate reductase model.
The sequencing of the Hf.voicanii citrate synthase will provide a 
representative of the halophiles for phylogenetic analysis, a group so 
far absent from the phylogenetic tree of citrate synthases. The N- 
terminal amino acid sequence of the Hf.voicanii citrate synthase 
indicates that the enzyme is, like that of Tp.acidophilum and
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B.coaguians, approximately 40 residues shorter than other citrate 
synthases. Two other Bacillus sequences have since been determined 
(A.L. Sonenshein, Tufts Univ. School of Medicine, Boston, USA, 
Unpublished), both of which are of the shorter type. This points to a 
relationship between the citrate synthases of the Archaea and the Gram 
positive Bacteria. The Gram positive Mycobacterium smegmatis also 
groups with the Archaea and Bacillus species on phylogenetic analysis 
(Taylor, G., Hough, D.W. and Danson, M.J., Unpublished data), 
although it does not lack the 40 or so N-terminal residues.
It is important in defining phylogenetic relationships between 
organisms to take a consensus from the phylogenetic relationships 
between as many of their genes as possible. Not all gene sequences 
will represent their parent organism in the same fashion as all have 
developed under slightly different conditions. It may be argued that all 
genes are valuable phylogenetically; however, our present techniques 
of analysis lack the sophistication to unlock the information within many 
sequences. Citrate synthase is a widespread central metabolic enzyme, 
functionally conserved in all organsims that possess it. It is a valuable 
addition to the growing range of enzymes whose gene sequences are a 
source of accessible phylogenetic information.
During the course of this project an open reading frame was 
idenfied within a cloned fragment of Hf.voicanii genomic DNA. It has 
been shown in Chapter Seven that this sequence bears significant 
homology with several enzymes from bacterial sources involved in the 
metabolism of nucleotide-activated hexose sugars. Such enzymes have 
been implicated in the biosynthesis of lipopolysaccharides and S-layer 
glycoproteins in halophilic Archaea. This is a subject area that has not 
yet been intensively studied at the genetic level and no gene coding for 
any of these activities has yet been cloned. Chapter Seven described
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possible approaches to characterise the function of the Hf.voicanii open 
reading frame.
If this sequence is a gene involved in polysaccharide metabolism 
it may provide a basis for further investigation into these pathways in 
the halobacteria, particularly if other genes of related function in the 
pathway are clustered with this one, as is the case in the Salmonella 
and Yersinia species studied to date. The sequencing of such a gene 
cluster, while a major project, would provide data from which a putative 
metabolic pathway could be deduced.
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Appendix
Purification of citrate synthase
Citrate synthase from Hf.voicanii was purified in our laboratory by 
Dr. M.J. Bonete, University of Alicante, Spain using a scheme based on 
that used to purify the H.halobium citrate synthase (James, 1990).








Cell-extract 2105 78.3 0.037 1 100
DEAE-
Sepharose
350 64.7 0.185 5 83
Hydroxylapatite 53.5 58.5 1.096 30 75
Mono-Q 7.8 37.3 4.78 129 48
Superdex-200 0.53 10.0 18.88 510 13
Superdex-200 0.13 3.4 25.8 697 4
SDS-polyacrylamide gel electrophoresis and Western blotting
The dried citrate synthase was dissolved in 40 pi Milli Q water. 
SDS-polyacrylamide gel electrophoresis was carried out on 2 pi aliquots 
using the Bio-Rad Protean II system. An initial gel was Coomassie stained 
to locate the protein bands, while subsequent ones were left unstained in 
order to carry out Western blots. The latter were used to optimise blotting
conditions. Figure 9.1 below shows a 0.5 fjl aliquot of the purified citrate 
synthase run on a small (Mini-Atto system) 8% SDS polyacrylamide gel. 
Two major protein bands are visible; one of 45 kD and another of 
approximately 55 kD.
The remaining 30 pi were electrophoresed as above and blotted 
onto Immobilon P membrane under the optimised conditions. The 
membranes were stained and both major protein bands (45 kD and 55 kD) 
were cut out. The bands were sequenced directly from the membrane.
N-terminal sequencing
Both protein bands were sequenced using an Applied Biosystems 
470A gas-phase Sequencer coupled to an Applied Biosystems 120 
Phenylthiohydantoin analyser.
Sequences were obtained for both 45 kD and 55 kD bands. These 
are shown below, using single letter amino acid codes where X indicates 
an unknown residue and residues in parentheses are tentative 
assignments.




9 7 k D -
6 6 k D -
45 kD—
-  55 kD
— 45 kD
Figure 9.1 SDS-PAGE of purified Hf.voicanii citrate synthase
Lane 1: Molecular weight markers 
Lane 2: Pig heart citrate synthase (4 pg)
Lane 3: Hf.voicanii citrate synthase ( 0.5 pi of 40 pi)
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Halophilic proteins are often highly acidic and thus bind less of a 
cationic detergent, such as SDS, than a non-halophilic protein. This results 
in reduced mobility on SDS gels and consequent over-estimates of protein 
molecular weight. It was therefore not possible to distinguish which of the 
two major bands was citrate synthase by migration distance alone. Based 
on the subunit sizes observed for citrate synthases from other sources, the 
45 kD band is closest to to the expected size of a citrate synthase 
monomer; however, the 55 kD band could be citrate synthase migrating 
slowly for the reasons described above. In the latter case the 45 kD band 
could either be a proteolytic degradation product of the larger band or a 
co-purified contaminant. It was therefore necessary to obtain N-terminal 
sequence for both of the bands.
The sequence of the 45 kD band was initially aligned by hand with a 
multiple sequence alignment of eight other citrate synthases. The 
sequences from both bands were used to search the Swissprot (1991) 
protein database, using the FASTA search program from the GCG 
program package. Only the 45 kD band showed significant homology with 
any of the sequences in the database. All of the best scores, with the 
exception of one, were obtained for matches to the N-termini of citrate 
synthases. The eight highest identities are shown in Table 9.1.
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Sequence Organism Swissprot 
Accession No.
Reference












P09948 Wood e ta i (1987)










P21553 Sutherland et al. 
(1990)
Citrate synthase Escherichia coli P00891 Bhayana & 
Duckworth (1984)
Table 9.1 Results of Swissprot database search
Alignments of available citrate synthase sequences show that the 
enzymes can be divided into two categories based on the presence or 
absence of a stretch of approximately 40 amino acids at the N-terminus 
(Muir et al., 1994a). The gene sequences of the Tp.acidophilum 
(Sutherland etai., 1991) and Bacillus sp. (Schendel ef al., 1992) citrate 
synthases, which are both of the shorter type, show that the absence of
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these residues is not due to proteolytic cleavage, but is coded for at the 
DNA level.
Figure 9.2 shows the relevant part of a citrate synthase multiple 
sequence alignment created using the PILEUP program from the GCG 
package. The alignment was created using the full sequences and 
includes the Hf.voicanii45 kD band sequence and the recently determined 
N-terminal sequences from S.soifataricus (Lill etai., 1992) and P.furiosus 
(Muir et al., 1994b) citrate synthases. It is evident that the Hf.voicanii N- 
terminal sequence aligns with the shorter N-termini and hence the enzyme 
belongs to the short category. It is unlikely that this observation is due to 
proteolytic cleavage of the Hf.voicanii N-terminus as the lack of these 
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Figure 9.2 Multiple sequence alignment of citrate synthases showing the Hf.voicanii N-terminal sequence
The alignment was created using the PILEUP from the GCG package. The entire citrate synthase sequences 
2? were used to create the alignment and the N-terminal sequence was then added by hand.
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